Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.8106246871459338,-2.2929304710839458,0.0,0.0,0.0,11/19,8.22%,GRM7;GRID2;GRIA4;GRM3;GRIK2;GRM5;GRIK4;GRIA1;GRIK1;GRIA2;GRM8
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7874367936285828,-2.1527789615537056,0.0,0.0015123212750456632,0.003,12/17,9.11%,GRIA4;GRIK2;GRIN3A;GRIK4;PTK2B;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1
prerank,ligand-gated channel activity (GO:0022834),-0.6883628475248178,-2.150598668388935,0.0,0.0010082141833637755,0.003,13/29,9.21%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;GABRB1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6813152408253467,-2.1504999146153048,0.0,0.0007561606375228316,0.003,18/29,20.36%,GRID2;GRIA4;GRIK2;GRIK4;GABRA2;GABRB3;GABRA3;GRIK1;GLRA3;GABRA4;GRIA2;GABRB1;GABRG3;GABRB2;GRIK3;GABRA5;GLRA2;GABRA1
prerank,ligand-gated ion channel activity (GO:0015276),-0.6841716136680309,-2.1425304687494613,0.0,0.0006049285100182653,0.003,13/30,9.21%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;GABRB1
prerank,retinoid binding (GO:0005501),0.7851341536779136,2.1090524718564043,0.0,0.004970364667807733,0.004,5/22,3.36%,ALDH1A2;RBP1;NR2F2;ABCA4;RBP4
prerank,cell adhesion mediator activity (GO:0098631),-0.6555110504237038,-1.9344608742782914,0.0,0.01764374820886607,0.087,11/24,10.36%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;BCAM;ROBO4;NPTN;JAM3;CNTN2;EMB
prerank,acetylation-dependent protein binding (GO:0140033),0.7397878009427271,1.9098768794721814,0.0,0.07886311939588271,0.184,10/20,15.46%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,lysine-acetylated histone binding (GO:0070577),0.7397878009427271,1.9098768794721814,0.0,0.07886311939588271,0.184,10/20,15.46%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6604806956299049,-1.89175298139769,0.004319654427645789,0.028950150122302693,0.162,10/19,16.65%,GRID2;GRIK2;GRIK4;GABRA2;GABRA3;GRIK1;GABRA4;GABRG3;GRIK3;GABRA5
prerank,cation:chloride symporter activity (GO:0015377),-0.7943092902088471,-1.8871967833777867,0.002053388090349076,0.027725890042503826,0.177,5/10,10.96%,SLC12A7;SLC12A2;SLC6A1;SLC12A5;SLC12A6
prerank,voltage-gated cation channel activity (GO:0022843),-0.46381821284735897,-1.871217614381604,0.0,0.03282297285839847,0.23,23/97,10.98%,KCNB2;KCND2;CACNA1E;KCNQ5;CACNB2;GRIN3A;KCNMA1;KCNH7;PTK2B;KCNC2;KCNQ3;CACNB4;HCN1;GRIN2A;OPRM1;GRIN2B;HCN2;KCNH1;KCNH5;GRIN1;KCND3;CACNA1D;KCNB1
prerank,phospholipase binding (GO:0043274),0.7729732937822816,1.8516751472921573,0.002028397565922921,0.14538316653337618,0.39,2/13,0.50%,PDPK1;ARHGAP6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7535275021385496,1.8494665619160204,0.0018281535648994515,0.12087926872108407,0.404,4/15,9.22%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7612898928731577,1.8354837175593224,0.0017825311942959,0.12541886845101513,0.474,4/13,9.22%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5919863858326285,-1.831487664475586,0.004694835680751174,0.049906602076506885,0.349,13/28,20.36%,GRID2;GRIK2;GRIK4;GABRA2;GABRA3;GRIK1;GABRA4;GABRG3;GRIK3;GABRA5;CHRNA4;CHRNA7;GABRA1
prerank,phospholipase activator activity (GO:0016004),0.8283790211399624,1.8270609911742313,0.0021008403361344537,0.11971478328462626,0.513,2/10,0.50%,PDPK1;ARHGAP6
prerank,ligand-gated anion channel activity (GO:0099095),-0.6727892375763667,-1.8251249942964363,0.0,0.04830262496660997,0.367,12/17,20.36%,GABRA2;GABRB3;GABRA3;GLRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GLRA2;GLRA1;GABRA1
prerank,glutamate receptor binding (GO:0035254),-0.6640040213287169,-1.8227172757978707,0.004545454545454545,0.04637785243473367,0.381,11/17,18.69%,SHANK3;HIP1;NSF;SYNDIG1;HOMER1;GNAS;SHANK2;CAMK2A;SHISA6;SHANK1;AKAP5
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.7009442328723134,-1.8153830161411562,0.0021413276231263384,0.04746362155527928,0.414,6/14,13.29%,KCNJ3;KCNJ2;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,lipase activator activity (GO:0060229),0.8183365446270556,1.8068614411997161,0.002136752136752137,0.13196318193029533,0.598,2/10,0.50%,PDPK1;ARHGAP6
prerank,sialyltransferase activity (GO:0008373),-0.6279204482692141,-1.805808890811217,0.002188183807439825,0.049330479686013305,0.446,9/20,18.70%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA6;ST6GALNAC4;ST6GALNAC5;ST3GAL4;ST6GAL2;ST8SIA5
prerank,AMP binding (GO:0016208),0.7573375360932204,1.757413445318125,0.013513513513513514,0.21085391446322138,0.802,2/11,1.15%,MPPED2;PRKAG2
prerank,GABA receptor activity (GO:0016917),-0.6113743065305678,-1.7532235451643325,0.0,0.08549656274924815,0.667,11/21,20.36%,GABRA2;GABBR2;GABRB3;GABRA3;GABRA4;GABRB1;GPR156;GABRG3;GABRB2;GABRA5;GABRA1
prerank,chloride channel activity (GO:0005254),-0.48220452132270947,-1.7505602521800712,0.0,0.08210644255768747,0.673,27/59,20.36%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;TTYH2;GABRB1;GABRG3;CLCN1;TTYH3;ANO2;GABRB2;TTYH1;FXYD1;GABRA5;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.7123688913648553,-1.7318475647264449,0.0041928721174004195,0.0943569862195157,0.747,5/11,13.29%,KCNJ3;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,cytokine activity (GO:0005125),0.4661966226982422,1.7278882383999372,0.0,0.26501984408750834,0.881,23/131,8.47%,BMP6;WNT4;CXCL10;WNT6;IL16;CXCL16;WNT10B;WNT3A;WNT2B;OSM;IL11;IL34;BMP2;IL17D;IL6;WNT5B;BMP7;CKLF;FAM3B;BMP8B;IL18;CCL2;WNT5A
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.540854584417891,-1.7131406102203752,0.0023752969121140144,0.10642260824395408,0.802,12/31,15.71%,SLC12A7;SLC12A2;KCNK5;ABCC9;HCN1;TMEM38B;KCNK10;TMEM175;SLC12A5;SLC12A6;KCNA2;KCNK9
prerank,wide pore channel activity (GO:0022829),0.6335557135963565,1.7079612030519786,0.010471204188481676,0.299306323268713,0.925,7/23,10.22%,GJB2;GJB6;PANX3;GJA1;PRF1;GJA3;PANX1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6536175092468087,-1.707674461186905,0.0,0.1068707034365602,0.817,9/13,20.36%,GABRA2;GABRA3;GLRA3;GABRA4;GABRG3;GABRA5;GLRA2;GLRA1;GABRA1
prerank,LRR domain binding (GO:0030275),0.7096733710575241,1.701038861987516,0.017341040462427744,0.29333435481178644,0.944,3/14,4.72%,ROBO1;PAWR;LRRFIP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6922842955159159,1.6781906945363068,0.02095238095238095,0.34012587757551993,0.973,2/14,0.80%,SLC7A11;SLC1A3
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6298962783174019,-1.6772571119719348,0.008908685968819599,0.12828325228323847,0.897,6/16,3.85%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6298962783174019,-1.6772571119719348,0.008908685968819599,0.12828325228323847,0.897,6/16,3.85%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6830271134375255,-1.6612168491546648,0.006276150627615063,0.14151660901033358,0.926,9/12,20.36%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.518647605282803,-1.6583175493342215,0.005089058524173028,0.13935273430058442,0.929,10/32,14.85%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNH1;KCNB1;KCNQ1;KCNE4;KCNC1;KCNA2
prerank,potassium channel activity (GO:0005267),-0.4193301571937873,-1.6537363727047933,0.0032258064516129032,0.13904953945558737,0.936,21/89,7.11%,KCNB2;KCND2;KCNQ5;GRIK2;KCNMB2;KCNK5;KCNMA1;ABCC9;KCNH7;GRIK4;KCNC2;KCNQ3;HCN1;GRIK1;KCNT1;TMEM38B;KCNK10;HCN2;KCNH1;TMEM175;KCNH5
prerank,frizzled binding (GO:0005109),0.5556904276244566,1.6433982104000235,0.013445378151260505,0.4278063874791656,0.992,10/34,15.18%,WNT4;WNT6;WNT10B;WNT3A;WNT2B;WNT5B;WNT5A;DVL3;RNF43;RYK
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6942887434279079,-1.6394237357540313,0.010548523206751054,0.15357118440997028,0.956,6/10,16.65%,SHANK3;NSF;GNAS;SHANK2;SHISA6;SHANK1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5364648728255699,1.6386141807853174,0.014705882352941176,0.41625147304667165,0.994,10/38,12.46%,TFPI;ANXA2;SERPING1;SERPINB7;SERPINE1;TFPI2;SPINT2;SERPINE2;SERPINB8;SERPINE3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6460433922591735,1.6360179730242244,0.012658227848101266,0.3993688010583513,0.994,2/18,0.33%,ALDH1A2;ALDH1A1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5103672277386253,1.6345560439541984,0.009478672985781991,0.3816070567307443,0.995,11/55,4.55%,PDPN;SLC7A2;SLC13A3;SLC6A13;SLC16A11;SLC19A1;SLC16A2;SLC16A12;SLC6A12;SLC7A14;SLC16A5
prerank,glycerophospholipid flippase activity (GO:0140333),-0.671167408725606,-1.6323424311216,0.014830508474576272,0.15728141260474898,0.964,7/11,8.59%,ATP8A1;ATP10A;ABCA3;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6506196815117617,1.6267144748108548,0.03717472118959108,0.3862525609627476,0.996,3/14,5.07%,SDR9C7;RDH10;RDH5
prerank,GABA-A receptor activity (GO:0004890),-0.589836182634686,-1.626128979818797,0.00641025641025641,0.15870038071466835,0.969,9/18,20.36%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,tropomyosin binding (GO:0005523),0.6514534931275858,1.6192600676490694,0.024163568773234202,0.3899905077246194,0.998,4/16,4.79%,TMOD3;CALD1;S100A6;NEBL
prerank,RNA polymerase II complex binding (GO:0000993),0.5454531808413873,1.617147007437857,0.027777777777777776,0.3766045308797919,0.998,12/32,19.38%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;BRD4;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6784084247137461,1.6105980578704382,0.026217228464419477,0.3790258085251097,0.998,5/13,7.35%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.44159935950871626,-1.6067560832862564,0.008746355685131196,0.18137053005726206,0.989,32/57,31.41%,COX4I1;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;CYBRD1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFB7;NDUFB10;NDUFC2;NDUFA4L2;NDUFA13;CYB5A;NDUFA9;UQCR10;UQCRQ;CYB561A3;NDUFA10;COX4I2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6199293722097245,1.605573643169257,0.02464788732394366,0.376934382353201,0.999,6/18,4.72%,TMOD3;ANXA2;ANXA1;RAB10;PKP3;BAIAP2L1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5965355796960481,-1.6050299037996683,0.033783783783783786,0.17810625039215935,0.991,6/15,2.67%,HS3ST1;HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5
prerank,BMP receptor binding (GO:0070700),0.6784130198062898,1.5921939296357026,0.03377110694183865,0.4029453025910565,1.0,5/12,7.35%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,filamin binding (GO:0031005),0.6943427603046808,1.5913921927472758,0.03373015873015873,0.3880612214390888,1.0,5/11,9.75%,DPYSL3;SYNPO2;NEBL;FBLIM1;RFLNA
prerank,cAMP response element binding (GO:0035497),0.7209516926381061,1.5910581538100914,0.024489795918367346,0.37361237134977165,1.0,4/10,9.91%,CREB5;CREB3L2;ATF7;E4F1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6442984382311885,-1.5877325193034688,0.023758099352051837,0.1982821227282092,0.995,5/12,13.49%,SLC6A6;SLC38A5;SLC1A4;SLC36A1;SLC3A2
prerank,anion channel activity (GO:0005253),-0.4321120280371774,-1.5876369301779618,0.008086253369272238,0.1921461095262318,0.995,26/61,20.36%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;GABRB1;LRRC8C;GABRG3;TTYH3;ANO2;GABRB2;VDAC1;FXYD1;GABRA5;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,SUMO transferase activity (GO:0019789),0.6343642108635468,1.5832181108456849,0.027777777777777776,0.38271807942119546,1.0,7/16,15.53%,RANBP2;HDAC4;PIAS1;NSMCE2;EGR2;CBX4;MUL1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.7165677108320633,1.5796297723621666,0.03861788617886179,0.37914678036358546,1.0,1/10,0.24%,DPYSL3
prerank,gap junction channel activity (GO:0005243),0.5989780907179906,1.5792001322994629,0.03046594982078853,0.3667419072746706,1.0,6/22,10.22%,GJB2;GJB6;PANX3;GJA1;GJA3;PANX1
prerank,transforming growth factor beta binding (GO:0050431),0.583189030415818,1.5766187745074582,0.036053130929791274,0.3619111045704417,1.0,7/23,6.94%,TGFBR3;LTBP1;TWSG1;LRRC32;WFIKKN1;TGFBR1;TGFBR2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5538495331831076,-1.576062701538387,0.021231422505307854,0.20504555954160786,0.997,4/19,3.76%,NRG3;EFNA5;GRM5;GAS6
prerank,amyloid-beta binding (GO:0001540),-0.40843535915895807,-1.5753012932982744,0.008645533141210375,0.20017634331513506,0.997,24/79,13.57%,APBB2;NLGN1;COL25A1;GRIA4;CST3;TGFB2;INSR;GRIA1;ITM2A;GRIN2A;SORL1;GRIA3;GRIN2B;APBA2;PFDN5;BCHE;GRIA2;LDLRAP1;GRIN1;CD74;ADRB2;PFDN2;CLSTN1;FZD4
prerank,pentosyltransferase activity (GO:0016763),0.5305480897481087,1.5697435988907495,0.015050167224080268,0.36916555176030635,1.0,13/36,12.48%,PARP14;ZC3HAV1;PARP9;LARGE1;LACC1;PARP3;PARP10;UPP1;PARP11;SIRT4;TIPARP;UMPS;PARP16
prerank,water transmembrane transporter activity (GO:0005372),0.6985671191325478,1.5681415590526757,0.03374777975133215,0.36174634720992926,1.0,2/11,5.94%,PDPN;SLC4A11
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.5524286387502444,-1.5661747876199674,0.028761061946902654,0.2098271635730022,0.997,7/20,14.55%,SLC39A10;SLC39A6;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8
prerank,hormone receptor binding (GO:0051427),0.6548103610945172,1.5659608488919634,0.04734848484848485,0.356437276240162,1.0,5/14,13.11%,GHRH;PTHLH;NCOA6;NPPC;JAK1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.5823987890826676,-1.5633571123566532,0.026200873362445413,0.20846988700010408,0.997,6/17,8.59%,ATP10A;PITPNC1;PITPNA;ABCA3;ATP8B2;ATP8B1
prerank,poly(U) RNA binding (GO:0008266),0.5986482253442973,1.557847444687086,0.021778584392014518,0.3665719251063776,1.0,7/20,8.08%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.5011180258340098,-1.5551343287315216,0.01873536299765808,0.21558979954262064,0.998,10/30,15.36%,SLC39A10;SLC40A1;SLC39A6;SLC31A1;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8;TTYH1
prerank,R-SMAD binding (GO:0070412),0.6046979057601131,1.5528102009378637,0.04909090909090909,0.3694150445750041,1.0,6/18,11.51%,SMAD3;PPM1A;LDLRAD4;PMEPA1;SMAD6;SMAD4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.395310969408902,1.5459234857541544,0.0,0.37834415851352465,1.0,58/232,17.01%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;MYCBP2;TRIM17;RNF19A;RNF216;DTX1;SIAH2;PELI2;TRIM5;DTX3L;BIRC3;MGRN1;ANAPC11;TRIM24;RNF111;PIAS1;RNF145;AMFR;UBR4;WWP2;HUWE1;RFWD3;HECTD1;CUL3;NSMCE2;TRIM21;EGR2;HECW2;TRIM26;TRIM7;CBX4;PRPF19;RNF39;BFAR;RNF43;RNF181;BRAP;RCHY1;MUL1;RNF180;RNF185;KCMF1;RING1;RNF2;RNF135
prerank,endopeptidase inhibitor activity (GO:0004866),0.4504772566799401,1.5451331939325035,0.0075528700906344415,0.3700436495182857,1.0,18/82,9.57%,TFPI;COL4A3;TIMP3;ANXA2;SERPING1;CSTB;ITIH2;SERPINB7;SERPINE1;TFPI2;BST2;SPINT2;PZP;TIMP2;SERPINE2;UBE2Z;PROS1;CAST
prerank,phospholipid transfer activity (GO:0120014),-0.5447230527410116,-1.539751319966133,0.04,0.23624910729091708,1.0,7/21,8.19%,CERT1;PITPNC1;PITPNA;ABCA3;GLTP;PRELID2;PRELID1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6139443632037958,1.5306435817663184,0.045112781954887216,0.39950985194757294,1.0,4/15,11.07%,KMT2A;KMT2C;SETD4;SETD1B
prerank,receptor ligand activity (GO:0048018),0.3874463931531262,1.5267327108373485,0.0,0.4001666753866047,1.0,31/245,7.74%,SEMA3D;BMP6;WNT4;PTN;DPP4;EPHA7;CXCL10;WNT6;IL16;FGF1;WNT10B;WNT3A;WNT2B;OSM;NBL1;IL11;VEGFD;TGFA;IL34;PTHLH;BMP2;IL17D;IL6;WNT5B;BMP7;FAM3B;SEMA4B;EDA;BMP8B;IL18;NPPC
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.556970571196508,1.5246157155025286,0.03454231433506045,0.3959978742515946,1.0,12/25,18.56%,PARP14;ZC3HAV1;PARP9;PARP3;PARP10;PARP11;SIRT4;TIPARP;PARP16;TNKS2;PARP4;SIRT3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.514731870558647,1.519555747294317,0.03333333333333333,0.3990705791782829,1.0,11/33,19.38%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,peptidase inhibitor activity (GO:0030414),0.5268507208139269,1.518686993814595,0.028192371475953566,0.3919799296802323,1.0,8/33,9.57%,TFPI;CSTB;ITIH2;SPINT2;PZP;TIMP2;PROS1;CAST
prerank,microtubule motor activity (GO:0003777),-0.4270704660428865,-1.517841224548927,0.015228426395939087,0.2695381023366472,1.0,30/51,38.46%,KIF1B;KIF26B;KIF21A;KIF1C;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;KIF15;KIF3B;DYNC1I2;KIF16B;KIF5A;KIF27;KIF23;KIF22;KIF4A;KIF14;KIFC3;KIF19;DNAH17;KIF20A;KIF20B;DNAH3;KIFC1;DYNLRB1;KIF2C;DNAH1;DYNLRB2
prerank,neurexin family protein binding (GO:0042043),-0.6445092358466857,-1.5120029892892406,0.043478260869565216,0.27340700521167405,1.0,4/10,8.74%,NLGN1;CPE;SYTL2;NLGN3
prerank,ubiquitin protein ligase activity (GO:0061630),0.38490378953639937,1.5108629365454234,0.003787878787878788,0.40352260581644783,1.0,57/228,17.83%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;MYCBP2;TRIM17;RNF19A;RNF216;DTX1;SIAH2;PELI2;TRIM5;DTX3L;BIRC3;MGRN1;ANAPC11;TRIM24;RNF111;RNF145;AMFR;UBR4;WWP2;HUWE1;RFWD3;HECTD1;CUL3;TRIM21;HECW2;TRIM26;TRIM7;PRPF19;RNF39;BFAR;RNF43;RNF181;BRAP;RCHY1;MUL1;RNF180;RNF185;KCMF1;RING1;RNF2;RNF135;SHPRH;UBE4B;TRIM3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5830552380370351,-1.509398838231616,0.054279749478079335,0.2711592046156874,1.0,5/13,12.65%,CCDC88A;ARHGDIB;GDI2;RANBP1;ARHGDIA
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3960037610025099,1.5061868185844633,0.005361930294906166,0.4077779645370261,1.0,36/181,12.36%,TCF7L2;SMAD3;RBPJ;ARNT2;NCOA3;PARP9;LDB2;DACT1;CRY1;TACC2;MIER3;ARNT;MTDH;PRRX1;CPNE1;BAZ2A;MIER1;TACC1;FOXP3;ANXA4;DTX3L;HDAC4;PPARA;CREBBP;POU1F1;STAT1;GSK3B;MEF2A;PIAS1;MAPK14;WWP2;RERE;ATN1;RBBP8;IFI27;EGR2
prerank,poly-pyrimidine tract binding (GO:0008187),0.5562151746647744,1.5021859733424725,0.03502626970227671,0.4090610121605764,1.0,7/23,8.08%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,ligand-gated cation channel activity (GO:0099094),-0.3916433049316524,-1.4984798112219884,0.0056022408963585435,0.28549674802081537,1.0,17/75,12.30%,GRIA4;GRIK2;GRIN3A;KCNJ3;KCNJ2;GRIK4;PTK2B;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;KCNJ6;KCNJ8;KCNJ15
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6341679508710846,1.4963335667872646,0.0796812749003984,0.41684791680680855,1.0,5/12,6.94%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,Tat protein binding (GO:0030957),-0.6339135224885489,-1.491984462869007,0.05241090146750524,0.2918059907850013,1.0,5/10,9.01%,ACTB;CTDP1;GABARAPL1;NPM1;SMARCB1
prerank,cholesterol transfer activity (GO:0120020),0.5980906865125409,1.4867732219564946,0.056672760511883,0.4336751224068069,1.0,2/16,2.03%,GRAMD1C;APOA2
prerank,protein kinase C activity (GO:0004697),-0.5871922859527183,-1.4835392469943194,0.051224944320712694,0.3014091471428217,1.0,4/14,5.93%,PRKCH;PRKCB;PRKCQ;PKN1
prerank,poly-purine tract binding (GO:0070717),0.5361296702983964,1.4814415794813782,0.05745062836624776,0.4395705910257367,1.0,5/27,5.43%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5
prerank,telomerase RNA binding (GO:0070034),0.5521625752816341,1.4798533572441064,0.06607142857142857,0.43451342123030856,1.0,12/22,21.67%,TERT;DCP2;HNRNPC;XRN1;SMG5;SMG6;SMG7;EXOSC10;DHX36;PARN;TENT4B;TEP1
prerank,sterol transfer activity (GO:0120015),0.5843935534912092,1.4763417362797722,0.06115107913669065,0.4361342841980843,1.0,2/17,2.03%,GRAMD1C;APOA2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.620673222300996,-1.4716268299026156,0.052521008403361345,0.31875607965394276,1.0,6/10,20.36%,GABRA2;GABRA3;GABRA4;GABRG3;GABRA5;GABRA1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3624721243079886,1.4715899132978285,0.0012121212121212121,0.4406526499891624,1.0,83/346,17.01%,RNF220;PDZRN3;CBLB;RNF152;RNF213;SMURF2;TRIM56;TRIM10;RNF217;TRAF5;FBXO11;SH3RF1;TRIP12;NEDD4;TTC3;NHLRC3;RC3H1;DTX4;BCOR;MYCBP2;TRIM17;RNF19A;KLHL21;UBE2U;RNF216;DTX1;DZIP3;SIAH2;CUL4A;PELI2;TRIM5;DTX3L;BIRC3;FBXO9;MGRN1;ANAPC11;RNF20;FBXL3;TRIM24;RNF111;RNF145;AMFR;UBE2Z;PJA2;UBR4;UBE2C;FBXO4;WWP2;FBXO24;HUWE1;RFWD3;HECTD1;CUL3;KLHL13;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;PRPF19;RNF39;FBXO3;BFAR;RNF43;RNF103-CHMP3;RNF181;BRAP;RCHY1;BIRC6;PML;UBE2R2;RNF146;MUL1;RNF180;RNF185;KCMF1;RING1;TRIM23;RNF2;RNF135
prerank,NAD+ binding (GO:0070403),0.6390104046187178,1.4712109205064754,0.06805293005671077,0.43294800000527595,1.0,3/12,4.43%,ZC3HAV1;PARP9;CRYL1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4832813527198506,-1.470896501197863,0.05502392344497608,0.3132633491509402,1.0,5/23,1.55%,PLCB1;EDNRA;CHRM3;PLCB4;PLCG2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6089591837899018,-1.4691706311841564,0.060851926977687626,0.3098724374868925,1.0,5/11,23.07%,PPP1R11;PPP1R1A;PPP1R14B;PPP1R14C;PPP1R8
prerank,MAP-kinase scaffold activity (GO:0005078),0.6514572146635059,1.46446333305014,0.0851063829787234,0.44220952113741724,1.0,3/11,3.27%,AKAP13;KSR1;SH3RF1
prerank,channel activity (GO:0015267),0.4771019179849689,1.463115136127568,0.054187192118226604,0.43711074937078953,1.0,7/41,10.22%,PDPN;PANX3;PRF1;BCL2;MPV17;BAX;PANX1
prerank,pyridoxal phosphate binding (GO:0030170),0.5407596393836406,1.461381709328249,0.07208872458410351,0.43383920046749946,1.0,5/20,10.09%,SHMT1;PYGB;PDXK;PYGM;ABAT
prerank,calcium channel regulator activity (GO:0005246),-0.43655812546674444,-1.4579035751622753,0.03201970443349754,0.32597495171055174,1.0,7/37,7.54%,PRKG1;NRXN1;FKBP1A;MCUB;CALM1;CALM2;SLC30A1
prerank,NAD binding (GO:0051287),0.5190401379089583,1.4574699397538962,0.05516014234875445,0.43661490647356876,1.0,7/26,12.39%,ALDH1A1;ZC3HAV1;PARP9;CRYL1;NNT;ALDH2;NUDT6
prerank,sterol binding (GO:0032934),0.4632811583505223,1.4568814646306436,0.04692556634304207,0.43043358023214967,1.0,16/56,15.36%,RORA;SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;INSIG2;SCP2;SOAT1;OSBPL5;STAR;ABCA1;OSBPL9
prerank,amino acid transmembrane transporter activity (GO:0015171),0.46900970750779414,1.4529939797536535,0.04311774461028192,0.4335378781650261,1.0,6/47,4.20%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC16A2;SLC7A14
prerank,acylglycerol lipase activity (GO:0047372),-0.6243615103252145,-1.4485417904080236,0.06471816283924843,0.33991521102866623,1.0,6/11,25.62%,MGLL;ABHD2;LIPE;ABHD6;FAAH;ABHD15
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.4402355491483858,-1.4477574825235673,0.05392156862745098,0.3281535524012416,1.0,21/34,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2;NDUFA6;NDUFS2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.4402355491483858,-1.4477574825235673,0.05392156862745098,0.3281535524012416,1.0,21/34,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2;NDUFA6;NDUFS2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.33557163902437215,1.4387668470400012,0.0010976948408342481,0.46450628698939717,1.0,177/731,19.21%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;CREB3L2;ARNT2;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;ZNF697;GATA6;SPIB;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;HLF;GLI1;ARNT;EN2;TOP1;GLIS3;GZF1;SALL1;PRRX1;MGA;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;STAT1;TRIM24;SKI;ZSCAN21;MEF2A;TEAD2;ATF7;ZNF182;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;MAFB;MSC;HEYL;ZNF235;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NFE2L1;NRF1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;ZNF260;MUC1;JDP2;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5;DNMT3A;ZFP1;ZNF467;KLF15;STAT5A;ATF2;RFX7;NKX2-1;NRIP1;ZSCAN25;MAFG;DHX36;FOXS1;NFYA;CLOCK;ESRRA;FOXP4;CEBPB;KLF6;PGR;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5962331244996008,-1.4382817423921612,0.07462686567164178,0.34190322159365677,1.0,2/10,3.43%,MECOM;PRDM16
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.33297254185561714,1.4362014991399943,0.002157497303128371,0.4632716844272591,1.0,171/831,16.65%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;ARNT2;OSR1;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;ZNF697;GATA6;SPIB;TCF24;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;ZBTB8A;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;EPAS1;HLF;GLI1;ARNT;EN2;SIM2;TOP1;AEBP1;GLIS3;GZF1;STOX1;SALL1;OTP;PRRX1;ZNF3;MGA;TCF12;KLF5;SP9;ZNF35;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;CREBRF;STAT1;SKI;ZSCAN21;MEF2A;NFXL1;ZNF25;TEAD2;ATF7;CUX1;ZNF182;ZFP37;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;RFXANK;MAFB;MSC;CUX2;HEYL;ZNF235;RFXAP;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;LHX9;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NFE2L1;NRF1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;VEZF1;POU5F1;ELK4;ZNF260;MUC1;JDP2;DRGX;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.49638043230523304,-1.4318082259711462,0.051094890510948905,0.3491135497240027,1.0,11/22,21.48%,ATP6V0A1;ATP6V1B2;ATP2C1;ATP2A3;ATP6V0C;ATP6V1D;ATP5F1B;ATP2A2;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3663578066043526,-1.4281510304352343,0.012461059190031152,0.35064928381027305,1.0,22/80,13.66%,KCNB2;KCND2;KCNQ5;KCNMA1;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNT1;HCN2;KCNH1;KCNH5;KCND3;KCNJ6;KCNB1;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1
prerank,phospholipase C activity (GO:0004629),-0.4670240646625042,-1.427626677242381,0.056790123456790124,0.34527601653604256,1.0,5/25,1.55%,PLCB1;EDNRA;CHRM3;PLCB4;PLCG2
prerank,sequence-specific DNA binding (GO:0043565),0.3354694576866825,1.4252180680185098,0.003389830508474576,0.48651586156724697,1.0,131/590,19.21%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;FOXD1;SMAD3;RBPJ;ZEB2;NR2F2;ELF1;ARNT2;OSR1;TEAD1;FOXC1;LBX1;NFAT5;GATA6;SPIB;MAF;ZBTB4;NR6A1;FOXC2;GLI3;NFATC4;ZIC4;MBD2;PRRX2;HIVEP1;HOXC4;ZIC1;RFX3;TERT;CREB3L4;EPAS1;HLF;ARNT;EN2;BCL2;ZNF276;GZF1;TCF12;KLF5;SP9;ZNF35;FOXP3;HDAC4;PPARA;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;MEF2A;TEAD2;ATF7;CUX1;SP8;ELF4;CREM;PBX1;MAFB;MSC;CUX2;SMG5;ELF2;TCF7;SMAD4;EGR3;SMG6;FOXO3;NR4A1;LHX9;KDM5B;EGR2;THAP1;HOXA10;BPTF;KDM2A;NFIC;BHLHE41;NR3C1;GMEB1;PKNOX1;HIC1;POU2F1;PRDM5;ERH;RFX2;SMG7;ZBTB21;ZBTB12;HDAC2;RARA;SP3;HOXB4;TEF;SOX4;IRF9;KDM2B;POU5F1;ELK4;MBNL2;JDP2;DRGX;BCL11B;POU6F1;NFATC2;UPF3A;ZFP1;LRWD1;SMG1;KLF15;ATF2;TEN1;HMBOX1;RFX7;KDM1A;MAFG;SIRT3;CLOCK;ESRRA;CEBPB;KLF6;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,platelet-derived growth factor binding (GO:0048407),0.613252410706753,1.4248447901733678,0.08431372549019608,0.47958315347184843,1.0,4/11,6.11%,COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.33221136838571985,1.4248074516536675,0.001095290251916758,0.4719281084911381,1.0,176/732,19.21%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;ARNT2;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;ZNF697;GATA6;SPIB;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;HLF;GLI1;ARNT;EN2;TOP1;GLIS3;GZF1;SALL1;PRRX1;MGA;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;STAT1;SKI;ZSCAN21;MEF2A;TEAD2;ATF7;ZNF182;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;TIPARP;MAFB;MSC;HEYL;ZNF235;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NFE2L1;NRF1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;ZNF260;MUC1;JDP2;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5;DNMT3A;ZFP1;ZNF467;KLF15;STAT5A;ATF2;RFX7;NKX2-1;NRIP1;ZSCAN25;MAFG;DHX36;FOXS1;NFYA;CLOCK;ESRRA;FOXP4;CEBPB;KLF6;PGR;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,outward rectifier potassium channel activity (GO:0015271),0.6344620861526679,1.4232908548305654,0.09487666034155598,0.46844503573928886,1.0,2/11,0.51%,KCNK2;KCNT2
prerank,translation elongation factor activity (GO:0003746),-0.554216677273371,-1.4196053571707299,0.08677685950413223,0.356284561233788,1.0,7/14,16.50%,EEF1A1;GTPBP1;EEF2;GFM1;EIF5A;EIF5AL1;EIF5A2
prerank,growth factor receptor binding (GO:0070851),0.39876182123379583,1.419471317092058,0.04052098408104197,0.47202931954586563,1.0,14/95,6.11%,EFEMP1;PDGFRA;FGF1;IL6ST;IL11;FRS2;FER;ITGA5;VEGFD;TGFA;KL;IL6;ARF4;PDGFRB
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5157406327586394,1.4190093074738774,0.07103825136612021,0.4659602175346646,1.0,10/27,15.90%,POLR2D;TERT;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;TENT2;POLR3H
prerank,motor activity (GO:0003774),-0.385410030497084,-1.409295580143021,0.03513513513513514,0.37233709868118287,1.0,33/60,38.46%,KIF1B;KIF26B;KIF21A;KIF1C;MYL6;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;KIF15;KIF3B;DYNC1I2;KIF16B;KIF5A;GPR88;KIF27;KIF23;KIF22;KIF4A;KIF14;KIFC3;KIF19;DNAH17;KIF20A;KIF20B;DNAH3;KIFC1;DYNLRB1;PIN1;KIF2C;DNAH1;DYNLRB2
prerank,alkali metal ion binding (GO:0031420),0.5918317103333686,1.4079810812208233,0.13424124513618677,0.4895507963568326,1.0,4/13,11.27%,ATP1A2;HDAC4;PDXK;ACAT1
prerank,C-C chemokine receptor activity (GO:0016493),0.5381905956386573,1.4079328508179718,0.09540636042402827,0.4823479264191922,1.0,6/21,17.30%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4;GPR75
prerank,diacylglycerol kinase activity (GO:0004143),-0.5781218276778185,-1.40586747089888,0.08686440677966102,0.3747019168487407,1.0,4/11,6.91%,DGKB;DGKI;DGKH;DGKZ
prerank,histone methyltransferase binding (GO:1990226),-0.5908052129306467,-1.405645261715586,0.08713692946058091,0.3686934970542358,1.0,8/11,28.91%,LCORL;CTNNB1;HSP90AB1;CBX3;NOP56;WIZ;CBX1;PRDM4
prerank,protein phosphatase 1 binding (GO:0008157),-0.4869419810916955,-1.4034374221601733,0.0779510022271715,0.36751970240008,1.0,9/21,23.86%,PPP1R16B;PHACTR4;PPP1R3B;PPP1R11;KCNQ1;PPP1R3C;SH3RF2;PPP1R15A;SMTNL2
prerank,retinoic acid binding (GO:0001972),0.5901207167385316,1.4015531849524714,0.11214953271028037,0.49268008833663596,1.0,1/12,0.95%,NR2F2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5225564984824391,-1.4010081525976665,0.0896551724137931,0.3668891413260779,1.0,5/16,8.67%,SLC26A7;SLC26A2;CLCN7;SLC1A1;SLC12A5
prerank,MHC class II protein complex binding (GO:0023026),-0.5816113782470214,-1.3996887351981007,0.08158995815899582,0.3635851738628907,1.0,6/11,12.81%,HSPA8;ATP1B1;PKM;HSP90AB1;CD74;HSP90AA1
prerank,phospholipase inhibitor activity (GO:0004859),0.6284255846785367,1.3990836726175715,0.11089108910891089,0.4920372884047464,1.0,7/10,21.39%,ANXA2;ANXA1;ANXA4;ANXA5;ANXA9;ANGPTL3;SNCB
prerank,RNA polymerase core enzyme binding (GO:0043175),0.46821922240509206,1.3986845456087882,0.07363013698630137,0.48595965409251607,1.0,12/33,19.46%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B;ERBB2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6101027362039316,1.3952246135078596,0.1183206106870229,0.48839783297785117,1.0,6/10,26.95%,NSD3;NSD1;SETD5;SETD2;ASH1L;SMYD2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5436139654097814,1.3935686385173813,0.09195402298850575,0.4858807594152493,1.0,5/18,6.94%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3643498640034613,1.3910076564976945,0.02091503267973856,0.4859110203873516,1.0,40/188,15.90%,TCF7L2;ZBTB20;SOX5;SMAD3;ARID4A;CREB3L2;TBL1XR1;FOXC1;NFYC;GATA6;FOXC2;CRY2;RFX3;GABPB2;GABPB1;GLI1;BCOR;TCF12;CREB3L3;NR1H3;HDAC4;GLIS2;YAP1;SMAD6;PBX1;TAF7;PSPC1;TCF7;SMAD4;FOXO3;EGR2;MZF1;ARID5B;PRDM5;DMTF1;CARM1;SOX4;PER3;POU5F1;TAF9
prerank,leak channel activity (GO:0022840),0.5415947920704132,1.3894240402797935,0.1088560885608856,0.4833612472352915,1.0,2/18,2.15%,KCNK2;NALCN
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5711257748626953,-1.3885643681750497,0.088,0.38133262257871836,1.0,7/12,13.74%,PDE4D;PDE4B;PDE8A;PDE3B;PDE3A;PDE2A;PDE4C
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6318104299510636,1.3884815765038712,0.13729508196721313,0.47943474870384356,1.0,3/10,9.40%,CXADR;CD47;DSC2
prerank,carboxylic acid binding (GO:0031406),-0.41035277569219686,-1.3831526428003489,0.043689320388349516,0.3877143654024474,1.0,15/38,22.81%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;SESN3;GRIN1;NOS1;GCLC;EPDR1;UBR1;GLRA2;GLRA1;HIF1AN;SHMT2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5497532702438299,1.3767866237168505,0.10971223021582734,0.5036418198261494,1.0,2/15,6.30%,PLA2G4A;PLA2G4C
prerank,bHLH transcription factor binding (GO:0043425),0.5414989427932357,1.374397575066984,0.13701067615658363,0.5039562472014095,1.0,4/19,6.75%,FHL2;SMAD3;TCF12;CREBBP
prerank,peptide hormone receptor binding (GO:0051428),0.6135877355098266,1.3691516510935295,0.14842300556586271,0.5113740571686802,1.0,2/11,3.78%,GHRH;PTHLH
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.40845033170707884,1.3679716654452596,0.057663125948406675,0.5081851834786915,1.0,20/69,16.77%,PLA2G4A;CERS5;CERS6;LIPT1;ZDHHC3;PLA2G4C;MOGAT3;CREBBP;SCP2;KAT6B;NAA16;ESCO1;SOAT1;NAA15;DGAT2;PORCN;KAT6A;ZDHHC17;KAT2B;LPGAT1
prerank,ribosomal large subunit binding (GO:0043023),-0.5717582971283317,-1.3595491254140017,0.12311015118790497,0.4360211276116028,1.0,7/11,29.95%,CPEB2;NPM1;RBM3;MALSU1;LTN1;EIF6;CPSF6
prerank,transcription cis-regulatory region binding (GO:0000976),0.3290192331506074,1.359440094294773,0.011723329425556858,0.5248705089204966,1.0,82/406,16.65%,TCF7L2;RORA;ZBTB20;SOX5;SMAD3;MXI1;ARID4A;CREB3L2;OSR1;TBL1XR1;TEAD1;FOXC1;NFYC;GATA6;TCF24;HIF3A;ZBTB4;ZNF395;FOXC2;GLI3;CRY2;ZBTB8A;RFX3;GABPB2;GABPB1;EPAS1;GLI1;BCOR;ARNT;SIM2;AEBP1;STOX1;OTP;ZNF3;TCF12;ZNF35;CREB3L3;NR1H3;HDAC4;GLIS2;CREBRF;MEF2A;NFXL1;ZNF25;CUX1;ZFP37;YAP1;CREM;SMAD6;E4F1;PBX1;TIPARP;RFXANK;TAF7;MSC;PSPC1;CUX2;RFXAP;TCF7;SMAD4;FOXO3;LHX9;EGR2;MZF1;NR3C1;ARID5B;PRDM5;SALL2;DMTF1;CARM1;RARA;SP3;SNAPC3;SOX4;PER3;VEZF1;POU5F1;TAF9;DRGX;SMAD2;TBL1X;ZBTB5
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4207453073291829,1.3579305159076493,0.07951070336391437,0.5225755504195583,1.0,17/60,9.85%,EFEMP1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;NRP1;KIT;ROR1;EPHA1;PDGFRB;EPHA4;MST1R;MUSK
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4340600896155541,-1.356158581135131,0.08717948717948718,0.43803028520296955,1.0,9/27,14.55%,SLC26A7;SLC26A2;ANO1;XPR1;SLC5A5;SLC39A14;SLC22A6;SLC25A30;SLC39A8
prerank,poly(A) binding (GO:0008143),0.5135702228946674,1.3508602606846336,0.12043795620437957,0.5355628543766098,1.0,4/21,5.43%,RBMS1;RBMS3;RBMS2;PABPC5
prerank,rRNA binding (GO:0019843),-0.3954989829655292,-1.3476465575973655,0.07017543859649122,0.4521993372111285,1.0,14/42,17.35%,RPS9;RPL5;RPS3;RPL11;RPLP0;RPS13;MRPS18A;RPL23;RPS5;PPAN;FASTKD2;RPS14;RPL12;ERI1
prerank,serotonin receptor activity (GO:0099589),-0.47327636652245453,-1.34423507661831,0.09382151029748284,0.44094028132418334,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.47327636652245453,-1.34423507661831,0.09382151029748284,0.44094028132418334,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.47327636652245453,-1.34423507661831,0.09382151029748284,0.44094028132418334,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5004945968323984,-1.342273046850904,0.14672686230248308,0.43339009684876656,1.0,8/16,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5004945968323984,-1.342273046850904,0.14672686230248308,0.43339009684876656,1.0,8/16,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,ion channel activity (GO:0005216),-0.3501449389444816,-1.339276358609315,0.048,0.43431626543348417,1.0,18/80,9.21%,GRID2;PIEZO2;GRIA4;GRIK2;GRIN3A;ABCC9;GRIK4;GRIA1;UNC80;MCUB;GRIN2A;GRIK1;GRIA3;GRIN2B;TRPC6;GRIA2;GRIN1;GABRB1
prerank,chemokine binding (GO:0019956),0.46939104590650266,1.338219525089576,0.11222780569514237,0.564369937051653,1.0,4/30,7.77%,PDPN;ACKR2;CCR9;ACKR3
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5717719345333825,-1.3375833328287015,0.13333333333333333,0.43252388466305963,1.0,4/10,17.85%,CACNB2;CACNB4;CACNA1D;CACNA1A
prerank,thyroid hormone receptor binding (GO:0046966),0.4801806506969887,1.3373006311962474,0.11478260869565217,0.5603849478921419,1.0,10/28,13.24%,NCOA3;TRIP12;NCOA6;TACC1;NSD1;OASL;TAF7;ZNHIT3;MED12;BRD8
prerank,monocarboxylic acid binding (GO:0033293),0.5201735336077316,1.336712330527154,0.13636363636363635,0.5553943954686806,1.0,3/18,16.06%,NR2F2;RARA;NAPEPLD
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.4013203021499384,-1.3355114824384995,0.08847184986595175,0.43135217628779904,1.0,17/37,33.70%,LARS2;KARS1;CARS1;EARS2;TARS3;IARS1;RARS2;VARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;PARS2;QARS1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.31502684730922154,1.3352805654622646,0.012263099219620958,0.5527854639734168,1.0,133/597,19.21%,TCF7L2;TCF4;CREB5;ZBTB20;SOX5;SMAD3;ARID4A;ELF1;CREB3L2;ARNT2;OSR1;TBL1XR1;TEAD1;FOXC1;LBX1;NFYC;NFAT5;GATA6;SPIB;MAF;NR6A1;FOXC2;ORC5;GLI3;NFATC4;ZIC4;MBD2;PRRX2;HIVEP1;CRY2;HOXC4;ZIC1;RFX3;GABPB2;GABPB1;CREB3L4;HLF;GLI1;BCOR;ARNT;EN2;ZNF276;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;TEAD2;ATF7;CUX1;SP8;YAP1;ELF4;CREM;SMAD6;PBX1;TAF7;MSC;MCM4;PSPC1;CUX2;ELF2;TCF7;SMAD4;EGR3;FOXO3;NR4A1;TSPYL2;LHX9;KDM5B;EGR2;HOXA10;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;MCM6;PKNOX1;HIC1;ARID5B;PRDM5;DMTF1;RFX2;ORC3;CARM1;ZBTB12;RARA;SP3;HOXB4;ORC4;TEF;SOX4;IRF9;PER3;POU5F1;ELK4;TAF9;MBNL2;JDP2;DRGX;BCL11B;POU6F1;NFATC2;TBL1X;CENPC;ZFP1;KLF15;ATF2;HMBOX1;RFX7;NKX2-1;MAFG;DHX36;NFYA;CLOCK;ESRRA;CEBPB;BRD7;KLF6;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,leucine zipper domain binding (GO:0043522),0.5982904594744352,1.3342149726554533,0.17519685039370078,0.5495509403744385,1.0,1/10,0.55%,PAWR
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5346397625972069,-1.3334017936459563,0.13771186440677965,0.4307897562676739,1.0,4/12,6.75%,INSR;PIK3R1;GNAS;YWHAH
prerank,potassium ion leak channel activity (GO:0022841),0.5366851290156334,1.332775922588366,0.15992647058823528,0.5474065941756703,1.0,1/15,0.04%,KCNK2
prerank,store-operated calcium channel activity (GO:0015279),-0.5601948235286496,-1.332294791668652,0.14049586776859505,0.42761547350720974,1.0,4/10,6.77%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.557736650509551,-1.3312611189817967,0.15555555555555556,0.42428795321713997,1.0,4/11,15.91%,SGMS1;SGMS2;PTDSS1;PIGO
prerank,sodium:proton antiporter activity (GO:0015385),-0.5533780177240039,-1.3286881908167738,0.1257606490872211,0.4251561656307859,1.0,3/11,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,nuclear localization sequence binding (GO:0008139),0.5223570487855966,1.3221201791859691,0.16308243727598568,0.571368549621808,1.0,6/18,14.30%,TNPO1;KPNA6;KPNA7;KPNA4;POM121;BRAP
prerank,calcium channel inhibitor activity (GO:0019855),-0.5465183763526111,-1.3218782651425853,0.15051546391752577,0.4353826185500657,1.0,5/11,7.54%,FKBP1A;MCUB;CALM1;CALM2;SLC30A1
prerank,intracellular chloride channel activity (GO:0061778),-0.4922580034147298,-1.3182092996548818,0.1350210970464135,0.43262346137252766,1.0,9/16,22.95%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4922580034147298,-1.3182092996548818,0.1350210970464135,0.43262346137252766,1.0,9/16,22.95%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,titin binding (GO:0031432),-0.5261616035729046,-1.3178203577982606,0.15670103092783505,0.4282697126210613,1.0,4/13,7.24%,CALM1;CALM2;CALM3;CAMK2D
prerank,nuclear import signal receptor activity (GO:0061608),0.5357627665466155,1.3177667022947472,0.17304189435336975,0.5779871393371353,1.0,4/15,7.24%,TNPO1;KPNA6;KPNA7;KPNA4
prerank,cholesterol binding (GO:0015485),0.43041616975287256,1.3134523838579135,0.12871287128712872,0.5834771164870647,1.0,13/47,14.75%,SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;SCP2;SOAT1;OSBPL5;STAR;ABCA1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.425595277760233,-1.3114514200910998,0.12391304347826088,0.4378686345507712,1.0,10/24,26.78%,ABCC9;KCNJ3;KCNJ2;KCNJ6;KCNJ8;KCNJ15;KCNJ10;KCNN3;KCNK1;KCNJ16
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5109096686855756,1.3072797246028502,0.16044776119402984,0.5950498970018254,1.0,6/18,11.18%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6;TGFBRAP1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.49483877599039644,1.3062177316662447,0.16064981949458484,0.5917513083322664,1.0,3/21,3.39%,FGF1;FRS2;KL
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5264446154825506,-1.306194624716452,0.1454183266932271,0.44456244211441526,1.0,3/12,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,chemokine activity (GO:0008009),0.4524745247766895,1.3047025240403172,0.14527027027027026,0.5896861792375042,1.0,4/31,7.71%,CXCL10;CXCL16;CKLF;CCL2
prerank,DNA-binding transcription factor binding (GO:0140297),0.3367141509457576,1.3012401092977708,0.07095046854082998,0.593597572369257,1.0,38/189,14.82%,TCF7L2;FHL2;SMAD3;RBPJ;TLE1;LDB2;DACT1;TLE3;MIER3;BCL2;MTDH;PRRX1;TCF12;MIER1;HDAC4;PPARA;CREBBP;POU1F1;STAT1;GSK3B;SKI;MEF2A;PIAS1;YAP1;CRTC1;CREM;WWP2;RERE;ATN1;CRTC3;RBBP8;IFI27;EGR2;BHLHE41;PRDM5;TLE6;RUNX1T1;HDAC2
prerank,protease binding (GO:0002020),0.3696014377913776,1.3010661831142465,0.06363636363636363,0.5877973966002208,1.0,20/99,9.34%,DPP4;COL3A1;FN1;ECM1;TIMP3;ANXA2;CSTB;ADAMTSL4;CFLAR;BCL2;SERPINE1;BDKRB2;POLG;GSK3B;RIPK2;PZP;TIMP2;AMFR;INSL3;SUMO1
prerank,FAD binding (GO:0071949),0.4825802027433751,1.300634146926501,0.1688073394495413,0.5827214543839495,1.0,5/24,4.60%,MICAL3;DDO;CRY2;CRY1;SQOR
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5139049258816575,-1.300379408584782,0.15274949083503056,0.45258141624033194,1.0,3/13,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,phosphoric diester hydrolase activity (GO:0008081),0.44141923930084137,1.2963833557953446,0.13667820069204153,0.5889070643243134,1.0,6/35,6.22%,ENPP3;MPPED2;SMPD3;ENPP1;PLCE1;PLCB3
prerank,DNA binding (GO:0003677),0.30250082623654057,1.2938364025796039,0.008762322015334063,0.5894250027575388,1.0,162/694,19.11%,TCF7L2;TCF4;RORA;TSHZ2;FOXD1;SMAD3;RBPJ;ZEB2;ARID4A;RBMS1;NR2F2;TEAD1;NUPR1;FOXC1;NFYC;DDX60;PDS5B;ZBTB4;ZNF395;DENND4A;SSBP2;NR6A1;ZIC2;FOXC2;ZIC4;NHEJ1;POLR2D;HIVEP2;CRY2;NUCKS1;RFX3;TERT;CRY1;WRN;EPAS1;HLF;GLI1;ARNT;SIM2;BCL2;TOP1;GZF1;OTP;ZBP1;ZNF3;RAD50;APLP2;HDGFL3;ZNF35;NR1H3;FOXP3;HDAC4;PPARA;TCF7L1;TSHZ3;CREBBP;RARB;RFC1;OASL;POLG;STAT1;FBH1;QRICH1;MEF2A;ZMYND11;NTHL1;CRLF3;SYCP2;CUX1;XRCC4;ACR;RLF;GLYR1;NABP1;CREM;HDGFL2;FUBP1;RPA3;SOX21;PBX1;MAFB;MCM4;CUX2;HUWE1;DCLRE1A;ZNF292;CENPX;POLR3F;XRN1;SMAD4;RTF1;ZMYM6;FOXO3;NR4A1;RBBP8;ZNF219;MTERF2;SPO11;ILF3;KDM5B;EGR2;OGG1;THAP1;TRIM26;BPTF;SUPV3L1;RBM5;MCM6;RAD51B;HIC1;ARID5B;RBM6;POU2F1;KAT6A;MND1;GTF2H4;ERCC5;ERCC6;PRDM5;RFX2;ZBTB21;HDAC2;DNASE1L1;SURF6;SNAPC3;ERCC1;SMARCA4;KDM2B;LIN9;POU5F1;ZMYM3;ELK4;APP;TAF9;SMAD2;TRIM16;POU6F1;NFATC2;DNMT3A;CENPC;CHD8;NUFIP1;JRKL;HMBOX1;C1D;PARP4;TSHZ1;NKX2-1;PCBP2;DHX36;FOXS1;SIRT3;NFYA;CHD4;CLOCK;ESRRA;CEBPB;PGR;E2F2;XPC;MEOX2;TDP2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.5430859633384088,-1.2937651721811343,0.14829659318637275,0.4619262238709242,1.0,2/11,6.59%,HCN1;HCN2
prerank,cadherin binding (GO:0045296),-0.277720939637636,-1.2936923573594217,0.016304347826086956,0.4568253230827589,1.0,81/315,14.88%,PTPRB;DOCK9;CTNND2;COBLL1;CTNNA2;BSG;ITGA6;PTPRJ;CDH2;CDH11;PROM1;FNBP1L;HSPA8;LRRFIP1;CDH12;CTNNA3;MRTFB;BMPR2;KDR;RPL24;FXYD5;NOTCH3;CDH1;CSNK1D;EPN2;PTPRM;ANK3;MACF1;DIAPH3;TRPC4;EEF1G;DAB2IP;CDH10;RPL6;CTNNB1;CLINT1;CDH8;MRE11;PUF60;PKM;CDH22;HSP90AB1;CDH4;EFHD2;TES;EEF2;RPS2;CDH7;CDH20;HNRNPK;RPL14;SHTN1;PCBP1;STXBP6;BZW2;RPS26;PTPRT;VASP;RACK1;CDC42EP1;CBL;DBNL;ARHGAP1;CD46;PPP1CA;PTPRO;ANLN;RPL29;EGFR;GPRC5A;RANBP1;ACVR1;SLC3A2;F11R;NOP56;EHD4;TJP2;MPP7;PARK7;GLOD4;PAK4
prerank,semaphorin receptor binding (GO:0030215),-0.4306991670446648,-1.293488772444778,0.15990990990990991,0.45203512050702,1.0,10/23,12.74%,SEMA6D;RIT2;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.40399239433968404,1.2922391379827611,0.1332263242375602,0.5879344958256411,1.0,4/53,2.88%,SLC7A11;SLC7A2;SLC1A3;SLC6A9
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3997690140055881,1.2902413492667495,0.1237785016286645,0.5874971037348741,1.0,10/53,6.79%,MICAL3;DDO;AOX1;CRY2;POR;CRY1;SQOR;ACOXL;NOS2;DPYD
prerank,fatty acid synthase activity (GO:0004312),-0.5369442018809293,-1.2898794456890832,0.1797520661157025,0.45506710067310363,1.0,2/10,3.52%,ELOVL5;ELOVL7
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5114755535848788,1.2879977571444445,0.16696914700544466,0.5880623608931738,1.0,4/17,9.97%,ACOT11;PLA2G6;ACOT9;ACOT1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.531645616142739,1.287705828830333,0.1894934333958724,0.5830672059047308,1.0,2/15,2.40%,ACKR2;CCR9
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5542984748673685,1.2865704368806252,0.1801980198019802,0.580414334083248,1.0,7/11,24.18%,ANAPC11;AMFR;PRPF19;UBE4B;UBR5;UBE2K;PPIL2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5837126690312366,1.2857051185125254,0.188212927756654,0.5772628861998261,1.0,2/10,1.15%,CXCL10;PRKAG2
prerank,amino acid binding (GO:0016597),-0.40397040403815004,-1.2810632433188782,0.1162227602905569,0.4701190713227133,1.0,7/31,10.30%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;GRIN1;NOS1
prerank,endopeptidase regulator activity (GO:0061135),0.42899737094545914,1.2784769119685018,0.12224108658743633,0.5916515783534378,1.0,7/40,9.57%,TFPI;CSTB;ITIH2;SPINT2;PZP;PROS1;CAST
prerank,voltage-gated ion channel activity (GO:0005244),-0.4881721750401442,-1.2776546994459625,0.16786570743405277,0.47252007369540283,1.0,3/14,3.19%,KCND2;CACNA1E;HCN1
prerank,GTPase inhibitor activity (GO:0005095),-0.5067570314377712,-1.2761637675147879,0.16942148760330578,0.47084698248070234,1.0,7/13,21.74%,SLIT2;CPEB2;TNK2;RHOH;PDE6D;GPS1;ARL2
prerank,lysine N-methyltransferase activity (GO:0016278),0.48319572122553167,1.2711999458220324,0.2038664323374341,0.6061893910463304,1.0,10/20,26.95%,METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;EHMT2;SETD6;EEF1AKMT4;SMYD2
prerank,glycine binding (GO:0016594),-0.535739805178794,-1.2692985553646587,0.18181818181818182,0.48165535432977613,1.0,8/11,28.99%,GRIN3A;GLRA3;GRIN2B;GRIN1;GLRA2;GLRA1;GLDC;GNMT
prerank,C-C chemokine binding (GO:0019957),0.4795219901280379,1.267848788345446,0.19434628975265017,0.6097164746757775,1.0,5/22,15.74%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4
prerank,translation initiation factor activity (GO:0003743),-0.3842151189876365,-1.2651575914408253,0.14420803782505912,0.48588415660172757,1.0,11/36,19.87%,EIF2B2;EIF3F;EIF5B;EIF4A1;EIF1B;EIF3A;COPS5;EIF1;EIF3H;EIF4A2;EIF3G
prerank,manganese ion binding (GO:0030145),0.39721265564233266,1.262496786870083,0.15422077922077923,0.6190520794240755,1.0,9/48,7.95%,MPPED2;FAM20C;WRN;LARGE1;GALNT2;GALNT1;GYG1;B4GALT1;NEK4
prerank,adenylate cyclase binding (GO:0008179),-0.5345637112387148,-1.2609889328549198,0.18958333333333333,0.4905439577204255,1.0,6/10,10.76%,AKAP6;CAP2;CALM1;CALM2;CALM3;ADCY2
prerank,histone acetyltransferase binding (GO:0035035),0.4856390868081853,1.2564951330161271,0.19320214669051877,0.629492166664515,1.0,12/21,24.07%,GLI3;EPAS1;FOXP3;STAT1;MEF2A;TAF7;KANSL1;CITED2;SIRT2;HIF1A;ECD;EGR1
prerank,retinoid X receptor binding (GO:0046965),0.5474571991659364,1.2551757195342306,0.20512820512820512,0.6276540680059549,1.0,5/11,20.36%,NCOA6;TACC1;NSD1;NRIP1;ARID5A
prerank,syntaxin-1 binding (GO:0017075),-0.42638513518343213,-1.2547459737917994,0.19523809523809524,0.500599346502268,1.0,7/22,9.75%,SYT1;SYNPR;NSF;SNAP25;STXBP1;CPLX1;SNPH
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4975306848505643,1.2537532277411347,0.18857142857142858,0.6263103263997369,1.0,4/16,13.40%,PIR;HGD;ALOXE3;BCO2
prerank,solute:anion antiporter activity (GO:0140323),0.5256433260748505,1.2525330032290607,0.21415929203539824,0.6241282514813367,1.0,2/14,3.50%,SLC7A11;SLC26A9
prerank,methyl-CpG binding (GO:0008327),0.4625098101089096,1.24962585168258,0.19746376811594202,0.6271030621930893,1.0,10/22,25.59%,ZBTB4;MBD2;ERH;ZBTB21;LRWD1;TET1;PRMT1;ZCWPW1;MECP2;ZBTB33
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3680156803057767,-1.2484374620532301,0.1407035175879397,0.5104889835229739,1.0,13/42,11.40%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;ROBO4;NPTN;JAM3;STXBP6;CNTN2;EMB;CDC42EP1;PPP1CA
prerank,calcium activated cation channel activity (GO:0005227),-0.45725409172680953,-1.2481203595906254,0.19747899159663865,0.5061646716479362,1.0,4/17,7.08%,KCNMB2;KCNMA1;ANO1;TMEM63C
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37120061759598827,1.2420621642591567,0.14174454828660435,0.6428712881904851,1.0,19/71,12.72%,PTPN13;EYA2;EYA1;TPTE;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;PTPN9;PTPN21;PTPN6;EYA4;CDC14A;PTPRU;PTPN1;PTPN18
prerank,actinin binding (GO:0042805),0.46222413833710996,1.2418755319900954,0.2110912343470483,0.6378606091705741,1.0,7/21,15.78%,CSRP3;DAG1;SYNPO2;CSRP1;CACNA1C;RARA;PKD2
prerank,regulatory RNA binding (GO:0061980),0.40770499159524926,1.2412788602506915,0.17398945518453426,0.6337852177694323,1.0,16/38,25.27%,TUT4;PIWIL4;RC3H1;TARBP2;ZC3H7B;POU5F1;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1;DHX9;ZC3H10;MATR3
prerank,kinesin binding (GO:0019894),-0.4098614734632288,-1.2408102868370998,0.170316301703163,0.5185581616434352,1.0,10/27,17.13%,KIF1B;ACTB;SNCA;AP1AR;MAPK8IP1;NEFH;CLSTN1;MAPK8IP3;TOR1B;PRC1
prerank,sodium channel activity (GO:0005272),-0.3695003425284969,-1.2399736969248212,0.15777262180974477,0.5153285155427265,1.0,10/37,11.70%,GRIK2;GRIK4;SCN1A;HCN1;GRIK1;HCN2;SCN2A;CACNA1G;SCN8A;SCN9A
prerank,insulin-like growth factor I binding (GO:0031994),0.535386862622325,1.2398058513534114,0.21978021978021978,0.6322725074796166,1.0,3/13,3.96%,IGFBP3;IGFBP5;IGFBP6
prerank,chemokine receptor binding (GO:0042379),0.4172961819329767,1.2394382263085622,0.19055374592833876,0.6279199518483558,1.0,6/35,15.02%,CXCL10;CXCL16;CKLF;CCL2;CCL25;CCRL2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.49741040956841986,-1.2362249355469297,0.1944990176817289,0.5193600745747575,1.0,6/12,19.24%,PIK3R6;PIK3C2B;PIK3R3;ATM;PIK3CD;PIK3C3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.38739762736565664,-1.235907705153693,0.17121588089330025,0.5151282565294427,1.0,8/32,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.44133990044361127,1.235576496040146,0.1891891891891892,0.6326031630952292,1.0,8/27,15.90%,POLR2D;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;POLR3H
prerank,potassium channel regulator activity (GO:0015459),-0.35213635586209413,-1.235287365504053,0.1246684350132626,0.5118204196089814,1.0,11/49,13.29%,DPP10;KCNAB1;KCNMB2;ABCC9;KCNIP4;KCNIP1;DPP6;AKT1;NEDD4L;ADRB2;KCNE4
prerank,nucleotide diphosphatase activity (GO:0004551),0.5258984598509044,1.2339777863493944,0.236328125,0.6318031808480759,1.0,6/14,18.67%,ENPP1;FHIT;NUDT13;NUDT6;NUDT4;CILP2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.41588100468219913,-1.2312709497569667,0.18588235294117647,0.5164867985295372,1.0,12/22,27.39%,SCN1A;HCN1;HCN2;SCN2A;CACNA1G;SCN8A;SCN9A;SCN3A;SCN2B;SCN1B;CACNA1I;HCN4
prerank,insulin-like growth factor binding (GO:0005520),0.5172734654190216,1.2309280295902245,0.2281021897810219,0.6351718638518298,1.0,3/15,3.96%,IGFBP3;IGFBP5;IGFBP6
prerank,amino acid:sodium symporter activity (GO:0005283),0.5416929527884847,1.229224661187352,0.23679060665362034,0.6347357728134695,1.0,3/11,3.95%,SLC1A3;SLC6A13;SLC6A12
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5552764017373002,1.2247167335488405,0.22645290581162325,0.6420027640194301,1.0,3/10,5.51%,CASP12;CFLAR;CASP4
prerank,RNA stem-loop binding (GO:0035613),0.5176838488159752,1.220976055947301,0.2447418738049713,0.6471414797485668,1.0,6/12,23.45%,RC3H1;METTL16;CPEB3;EPRS1;ZC3H12A;DHX9
prerank,actin binding (GO:0003779),-0.28049339937727535,-1.2205478278213084,0.06785714285714285,0.5380310984421184,1.0,49/170,18.47%,SYNE1;MYRIP;SSH2;PARVB;DMD;NOS3;FMN2;TMSB4X;KCNMA1;KLHL2;CAP2;EPS8;FXYD5;PHACTR4;UTRN;SNCA;MACF1;KLHL1;TMSB10;TLN2;MOBP;SPTB;CCDC88A;MSRB2;MAP1B;CEACAM1;MSRB1;CORO7;ARPC1A;KIF18A;DBNL;PDLIM3;MLPH;ANLN;ACTN4;PHACTR3;MAPT;NOD2;TWF1;FHL3;ADD1;ADCY8;SSH3;LDB3;GAS2L3;LCP1;HPCA;PACRG;MAEA
prerank,Hsp90 protein binding (GO:0051879),-0.3844653448463451,-1.2169108373920097,0.1883720930232558,0.541848543376109,1.0,10/33,19.43%,SLC12A2;KDR;RPS3;HDAC6;UNC45B;NPAS2;MAPT;NOD2;PACRG;AHSA1
prerank,glucuronosyltransferase activity (GO:0015020),-0.42781321934396804,-1.2151062568463473,0.20634920634920634,0.5411754524048138,1.0,3/19,5.29%,CSGALNACT1;EXT1;B3GAT2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.39104341451454894,-1.2150816480829967,0.19036144578313252,0.5362485864348644,1.0,14/28,32.14%,PRORP;RPP30;DBR1;NUDT16L1;DICER1;ENDOV;EXO1;EDC3;POP7;NUDT16;MRPL44;APEX1;FEN1;ELAC1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.525761381470493,1.2150791672499581,0.24514991181657847,0.6581551766950107,1.0,3/12,12.60%,SULF1;ARSI;ARSB
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5106611594140749,-1.214107194157121,0.23958333333333334,0.5338355355840085,1.0,2/11,1.65%,KCNMB2;KCNMA1
prerank,double-stranded DNA binding (GO:0003690),0.28718104681927575,1.2128028495531928,0.07126436781609195,0.6595165136695181,1.0,98/531,16.48%,TCF4;CREB5;ZBTB20;RBMS1;ELF1;ARNT2;OSR1;TEAD1;LBX1;NFAT5;DDX60;GATA6;SPIB;MAF;NR6A1;FOXC2;GLI3;NFATC4;ZIC4;PRRX2;HIVEP1;NUCKS1;HOXC4;ZIC1;RFX3;CRY1;CREB3L4;HLF;ARNT;EN2;ZNF276;TOP1;ZBP1;TCF12;RAD50;KLF5;HDGFL3;SP9;FOXP3;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;STAT1;FBH1;ZMYND11;NTHL1;TEAD2;ATF7;CUX1;SP8;ELF4;CREM;HDGFL2;PBX1;MSC;CUX2;CENPX;POLR3F;ELF2;TCF7;EGR3;FOXO3;NR4A1;RBBP8;LHX9;KDM5B;EGR2;HOXA10;NFIC;BHLHE41;NR3C1;GMEB1;RAD51B;PKNOX1;HIC1;MND1;GTF2H4;ERCC5;RFX2;ZBTB12;RARA;SP3;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;MBNL2;JDP2;DRGX;SMAD2;BCL11B;POU6F1;NFATC2
prerank,telomeric DNA binding (GO:0042162),0.414742709038588,1.2127341814697006,0.20695364238410596,0.6545659619711047,1.0,14/32,20.10%,TERT;WRN;RAD50;SMG5;SMG6;SMG7;HNRNPA2B1;UPF3A;SMG1;TEN1;HMBOX1;KDM1A;UPF2;CTC1
prerank,mRNA 3'-UTR binding (GO:0003730),0.3522995573183831,1.2125879581364851,0.16113744075829384,0.6499849906980568,1.0,11/79,8.08%,CELF2;RBMS1;RBMS3;RC3H1;RBMS2;IGF2BP1;PABPC5;SECISBP2L;CPEB1;RNF20;HNRNPC
prerank,MAP kinase kinase activity (GO:0004708),0.49344123271463725,1.212230781643527,0.25426944971537,0.6459791790877872,1.0,8/15,18.81%,MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAPKAPK3;MAP2K4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.28001428884685137,-1.212149321187968,0.06772908366533864,0.5337119263388421,1.0,36/147,13.37%,RAPGEF5;DOCK9;DOCK4;FGD5;ARHGEF28;CYTH3;PREX2;RASGRF2;ELMO1;ABR;DOCK10;SPATA13;CYTH1;TIAM1;DOCK2;ARHGEF6;ARHGEF15;RAB3GAP1;ARHGEF2;EIF2B2;FGD6;PREX1;RAPGEF2;CCDC88A;HERC2;SMCR8;SH3BP5L;BCR;DOCK8;ALS2;ARHGEF7;VAV1;RGP1;DOCK1;RAPGEF6;RABGEF1
prerank,I-SMAD binding (GO:0070411),0.5115204189359815,1.2116124356457754,0.23166023166023167,0.6427098874340635,1.0,5/13,11.51%,SMAD3;TGFB1I1;TGFBR1;SMAD6;SMAD4
prerank,GTPase activator activity (GO:0005096),0.29902893798588615,1.2105859720010685,0.10047846889952153,0.6406724748248595,1.0,61/313,13.39%,ARHGAP29;RANBP3L;ALDH1A1;RASGRF1;RIN2;RAPGEF4;AKAP13;ARHGAP10;ARHGAP42;DOCK5;DOCK11;ARHGAP20;ARHGAP18;SBF2;ASAP1;DLC1;DENND2A;DENND4A;ARHGAP28;ARFGAP3;ARHGAP32;FGD4;RCBTB2;NRP1;TBC1D16;PCP2;ERRFI1;SEC23A;MYCBP2;RANBP2;PLCE1;ASAP3;GRTP1;RASA1;TAGAP;RALBP1;DENND1A;ARHGEF10L;ARHGEF11;ACAP2;ARHGAP26;SYDE1;GMIP;EIF2B3;LRRK2;HPS1;IQGAP2;NGEF;DNM1L;FNIP1;IQSEC2;NUCB2;ARHGAP9;RAB3IP;SIPA1L2;RAP1GAP;ARRB1;GNB5;SMAP2;LLGL2;NPRL3
prerank,transcription coactivator binding (GO:0001223),0.4705091938660625,1.2102119772011704,0.2309090909090909,0.6369017811096246,1.0,6/20,12.21%,RORA;SMAD3;TERT;TEAD2;SMAD4;VGLL4
prerank,histone acetyltransferase activity (GO:0004402),0.41462704494284053,1.2090960462319034,0.2322695035460993,0.635390647459302,1.0,14/30,20.13%,NCOA3;CREBBP;KAT6B;EPC1;BAZ1A;SRCAP;ARRB1;KAT6A;KAT2B;TAF9;ATF2;CLOCK;EPC2;NAA40
prerank,symporter activity (GO:0015293),-0.5161858737706724,-1.208146128507241,0.238,0.5378686423085828,1.0,3/10,13.08%,SLC5A5;SLC5A6;MFSD2A
prerank,O-acyltransferase activity (GO:0008374),0.4180458680314768,1.2070623221935581,0.23842195540308747,0.6363686745500443,1.0,6/30,12.05%,PLA2G4A;MBOAT2;PLA2G4C;MOGAT3;SOAT1;DGAT2
prerank,semaphorin receptor activity (GO:0017154),0.5373816928076629,1.2066417325236838,0.2795497185741088,0.6330197966041484,1.0,2/11,2.97%,PLXNA2;NRP1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5019423789426974,1.2055995199017995,0.25621414913957935,0.6310984486821101,1.0,1/13,0.34%,SLC7A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.38986945864416694,-1.20473757718952,0.19221967963386727,0.5412219763069667,1.0,8/27,18.12%,SLC9A2;SLC9B2;SLC8A1;SLC9A8;CNNM4;SLC3A2;SLC9A5;SLC8B1
prerank,tubulin binding (GO:0015631),-0.25845570582362065,-1.2036752131703083,0.043010752688172046,0.5390198536243873,1.0,73/295,18.18%,DNM3;MTUS1;SGIP1;UNC5C;AGBL4;SYBU;NAV3;TTLL7;DIP2B;MID1;KIF1B;EML6;REEP1;PAK1;KIF26B;SNCA;KIF21A;RPS3;KIF1C;FMN1;RP1;STARD9;TTLL5;ARHGEF2;GABARAP;CRIPT;MID2;STMN2;CCDC88A;EFHC2;DIXDC1;RCC2;MTCL1;MAP1B;PHF6;TERF1;HDAC6;GABARAPL1;ARL8A;SNPH;KIF26A;KIF18A;NEFH;FGF13;TRIM36;ARHGEF7;KIF5C;PRUNE1;WASHC1;KIF15;KIF3B;NDE1;CLASP2;RAE1;KIF16B;BRCA2;RAB11FIP5;KIF5A;MAPT;CLIP2;KRIT1;MAP2;SKA2;STMN4;CCDC69;GAS2L3;BRCA1;PRC1;CCT5;KIF27;TPPP;STMN1;PACRG
prerank,protein serine/threonine kinase activity (GO:0004674),0.2947182583879137,1.2015563023426492,0.1027479091995221,0.637704990306787,1.0,75/334,15.81%,PDPK1;ROCK2;CAMK1D;NRK;STK32B;GRK3;FAM20C;MAPK4;STK39;PRKAA2;OXSR1;EIF2AK2;TSSK3;BMPR1A;BMP2K;CASK;FAM20A;CDK8;DAPK1;TAOK3;NEK8;IKBKE;PRKCZ;TOP1;ARAF;LATS2;MAP3K1;AAK1;TGFBR1;MAPK6;TGFBR2;MAP4K1;CLK4;GSK3B;NEK4;WNK4;RIPK2;STK24;STK3;SIK3;LRRK2;TLK2;CDK7;CDK12;BRD4;CDK16;MAPK14;AKT3;HIPK3;GRK5;IRAK3;MAP3K7;RPS6KA3;MASTL;DAPK2;MAP2K1;MAP3K13;SRPK1;MAPK9;ACVR1C;WNK1;MAPKAPK5;TBK1;NUAK2;CSNK2A2;MAP3K2;EIF2AK3;ILK;LIMK1;CDKL3;STK4;ACVR2B;PKN2;PRKD2;ERN2
prerank,transition metal ion binding (GO:0046914),0.28943409681211685,1.1990668294784093,0.08518086347724621,0.6396609021334202,1.0,74/397,14.53%,KMT2A;AGMO;ENPP3;MPPED2;CBLB;SMAD3;MOXD1;FAM20C;ENPP1;PAPPA;KDM7A;SHMT1;AOX1;RC3H1;LITAF;LOXL3;WRN;UBA5;LARGE1;ANPEP;SEC23A;LACC1;MYCBP2;PAM;ZNF3;CSRP1;GALNT2;HDAC4;CUTA;NPEPPS;GALNT1;NSD1;SEC24D;GLO1;GYG1;B4GALT1;TRIM24;SKI;NEK4;ZMYND11;TIMP2;BAZ1B;ZFP37;ZEB1;ACR;PDXK;SLU7;MNAT1;QPCTL;ERAP1;CUTC;ENPP2;SCD5;ESCO1;ENDOU;SEC24C;ZCCHC4;FNTB;KDM5B;NQO2;EEA1;THAP1;PTPN1;KDM2A;TET2;PPM1M;TIMM9;RNPEP;ZNF205;KAT6A;LNPEP;MDM4;IFIH1;RCHY1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.36179228740321634,-1.197149321467288,0.20055710306406685,0.5496978295348725,1.0,17/37,24.50%,SLCO1C1;SLCO2A1;COX4I1;UQCRH;SLC16A7;UQCR11;SLC22A6;COX8A;NDUFA4;COX6A1;SLCO4A1;NDUFA4L2;SLCO4C1;CYB5A;SLCO1B1;UQCR10;UQCRQ
prerank,protein tyrosine kinase activity (GO:0004713),0.3376612082727323,1.1952224876126325,0.18,0.6451178312766737,1.0,29/108,15.94%,TEC;STYK1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;FER;KIT;ROR1;EPHA1;PDGFRB;EPHA4;BAZ1B;MST1R;MUSK;HIPK3;PTK2;EPHA2;JAK1;ALK;FRK;NTRK3;RYK;TXK;IGF1R
prerank,protein heterodimerization activity (GO:0046982),0.3136988183803874,1.1924684593464725,0.14690026954177898,0.6479310979652966,1.0,28/178,11.86%,TCF4;BMP6;ATP1A2;ZHX2;MICU1;ARNT2;APOA2;DGKD;EPAS1;TLR4;ARNT;BCL2;TPM1;MCL1;CREB3L3;TOP2B;BDKRB2;VAPA;MEF2A;PHB2;BAX;TPM4;TAF7;PAFAH1B3;BCL2L1;IRAK3;ATP1B2;NR4A1
prerank,nucleotidyltransferase activity (GO:0016779),0.44904130843071266,1.1924330182666194,0.23508137432188064,0.6434452085589859,1.0,9/19,22.62%,TUT4;TERT;REV1;TENT2;CRPPA;TUT7;PAPSS1;TENT4B;PNPT1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.48981881942028704,-1.1919886883682234,0.24896265560165975,0.5575249092404571,1.0,6/10,23.42%,SLCO1C1;SLCO2A1;SLC22A6;SLCO4A1;SLCO4C1;SLCO1B1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4678125459423429,-1.1906896526889195,0.2454728370221328,0.5555781640429246,1.0,7/14,20.73%,NOD1;MAL;ATP2A3;RACK1;PYCARD;CASP1;BAD
prerank,CXCR chemokine receptor binding (GO:0045236),0.510214556466903,1.189297188001671,0.28,0.6475307670512204,1.0,1/11,1.07%,CXCL10
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.43647900772138926,1.1882607291066993,0.2427536231884058,0.6457953393177023,1.0,3/23,1.53%,PDE1A;PDE8B;PDE5A
prerank,exonuclease activity (GO:0004527),0.3899663368221737,1.186595171103022,0.22297297297297297,0.6455783857564839,1.0,8/46,10.74%,ENPP3;ENPP1;REXO5;WRN;RAD50;POLG;EXD1;ENPP2
prerank,ephrin receptor activity (GO:0005003),0.4733119436346871,1.1861754381189227,0.2777777777777778,0.6380054761210726,1.0,6/17,12.29%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4733119436346871,1.1861754381189227,0.2777777777777778,0.6380054761210726,1.0,6/17,12.29%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,chemokine receptor activity (GO:0004950),0.43707192439705006,1.1856890976158725,0.24691358024691357,0.6351320040377016,1.0,6/24,17.30%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4;GPR75
prerank,pre-mRNA binding (GO:0036002),0.42366419282115764,1.1820582603886345,0.24168126094570927,0.6401162529093701,1.0,5/28,10.38%,CELF2;RBM41;ZRSR2;SLU7;RNPC3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.34855341533367323,1.1810313645288921,0.2288261515601783,0.6382544677225266,1.0,13/73,11.10%,LGR4;FPR2;GCGR;GP1BA;GLP2R;MC2R;SORCS2;RXFP2;BDKRB2;OPRD1;NMUR1;MAS1;NLRP6
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.37247541912941456,1.1803906078811912,0.24707846410684475,0.635680016322536,1.0,11/48,11.89%,TRPM3;TRPM6;NALCN;P2RX1;SLC4A11;CALHM2;TMEM165;PKD1L3;TRPC1;GRIN3B;SLC41A1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5094925367655498,-1.179617094081028,0.26229508196721313,0.5772413974443523,1.0,9/10,33.79%,MGME1;EXD2;DCLRE1C;POLD1;EXO1;APEX1;DCLRE1B;FEN1;TATDN1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.44861169620025787,1.1784924070464275,0.24334600760456274,0.6362393772469412,1.0,3/21,1.53%,PDE1A;PDE8B;PDE5A
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5129360080203771,-1.1773025380185518,0.2732793522267207,0.5783731737310228,1.0,4/10,16.91%,ANO1;CLCN3;CLCN1;CLCN5
prerank,hexose transmembrane transporter activity (GO:0015149),-0.48152205411128873,-1.1761397013366488,0.26881720430107525,0.5763342001959733,1.0,8/12,43.33%,SLC2A1;SLC2A4;SLC2A2;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,cytokine receptor binding (GO:0005126),0.3383237120408181,1.1743023643482815,0.21021021021021022,0.6427558638652071,1.0,20/83,16.33%,TGFBR3;SMAD3;IL6ST;OSM;IL11;VEGFD;IL34;IL6;IL18;IL13RA1;ERAP1;TGFBRAP1;SH2B3;CSF1;JAK1;IL22;CCL25;CCRL2;IL23R;SMAD2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5189973336342094,1.1702470664513276,0.2803921568627451,0.6489553401013642,1.0,3/11,5.51%,CASP12;CFLAR;CASP4
prerank,miRNA binding (GO:0035198),0.39848299655647745,1.1685070540159914,0.24865831842576028,0.6492065861008689,1.0,13/30,25.27%,TUT4;RC3H1;ZC3H7B;POU5F1;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1;ZC3H10;MATR3
prerank,nuclear receptor binding (GO:0016922),0.3255111651490955,1.1640530964158051,0.20056497175141244,0.6568782966875543,1.0,21/111,13.24%,TCF7L2;SMAD3;NCOA3;TRIP12;TGFB1I1;STAT5B;CRY1;TACC2;NCOA6;BAZ2A;TACC1;NSD1;OASL;STAT1;PHB2;TAF7;PPID;ZNHIT3;NR4A1;MED12;BRD8
prerank,glucose transmembrane transporter activity (GO:0005355),-0.42807246316784486,-1.1631895913954486,0.26490066225165565,0.6028784745120922,1.0,10/17,43.33%,SLC2A1;SLC2A4;SLC2A2;SLC5A11;SLC2A10;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,protein phosphatase regulator activity (GO:0019888),0.36250703998499095,1.1625907414610623,0.23817292006525284,0.6564553732853123,1.0,11/53,12.87%,RCAN2;PTN;PPP2R2B;EIF2AK2;RCAN1;PPP4R2;PPP4R1;PPP6R3;PPP1R16A;PPP1R7;SHOC2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4799260130035736,1.1596431355545278,0.27787934186471663,0.6601776767000829,1.0,2/14,9.45%,CMPK2;AK5
prerank,GTPase regulator activity (GO:0030695),0.297130921102201,1.1576387703166975,0.17861799217731422,0.6611710373769448,1.0,44/212,13.91%,ARHGAP29;RANBP3L;ALDH1A1;RIN2;ARHGAP10;ARHGAP42;ARHGAP20;ARHGAP18;ASAP1;DLC1;ARHGAP28;ARFGAP3;ARHGAP32;NRP1;TBC1D16;ERRFI1;SEC23A;RANBP2;ASAP3;GRTP1;RASA1;TAGAP;RALBP1;ARHGEF10L;ACAP2;ARHGAP26;SYDE1;GMIP;LRRK2;IQGAP2;RALGDS;DNM1L;IPO7;ARHGAP9;SIPA1L2;RAP1GAP;ARRB1;GNB5;SMAP2;LLGL2;NPRL3;WASL;TBC1D7;CDC42SE1
prerank,PDZ domain binding (GO:0030165),0.34698617346405713,1.1566548156546421,0.24115755627009647,0.6595611784622514,1.0,6/61,3.42%,ARHGAP29;TGFBR3;PLEKHA2;CXADR;SDC2;FZD2
prerank,actin monomer binding (GO:0003785),-0.3895304109417157,-1.1557323794170489,0.2543859649122807,0.6160188660352669,1.0,8/22,24.78%,NOS3;TMSB4X;TMSB10;TWF1;PFN2;ABITRAM;PRKCE;PFN1
prerank,iron ion binding (GO:0005506),0.371525074285448,1.1542861909335533,0.2640901771336554,0.6618055991101115,1.0,9/48,15.10%,AGMO;KDM7A;AOX1;FECH;FTO;SCD5;TET2;PHYH;ALKBH1
prerank,growth factor activity (GO:0008083),0.34113382449726926,1.1539247042126348,0.25113464447806355,0.6587083160434033,1.0,19/74,19.82%,PTN;FGF1;OSM;IL11;VEGFD;TGFA;IL6;IGF2;FGF18;ENDOU;CSF1;BDNF;INHA;OSGIN2;OSGIN1;GDNF;IL7;HBEGF;ANGPTL3
prerank,chemorepellent activity (GO:0045499),0.4213864208045537,1.1519230810477683,0.28161888701517707,0.660015639029232,1.0,3/25,1.02%,SEMA3D;DPP4;EPHA7
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.39461255325059713,1.1515397220771482,0.27902946273830154,0.6569791649386302,1.0,15/32,23.27%,KDM7A;P4HTM;FTO;TMLHE;KDM2A;TET2;KDM8;PHYH;ALKBH1;KDM2B;ALKBH4;EGLN1;TET1;PHF8;HSPBAP1
prerank,nuclease activity (GO:0004518),0.3618145487387212,1.1501490271116455,0.2633279483037157,0.656533962799612,1.0,18/52,22.02%,ENPP1;REXO5;WRN;NTHL1;SND1;OGG1;ERCC5;DNASE1L1;DIS3;ERN2;RNASEH1;RNASE3;DFFB;DNA2;RNASEL;PARN;STK31;ZC3H12A
prerank,copper ion binding (GO:0005507),0.3789947848175367,1.1467543581329993,0.26533996683250416,0.6615914676322054,1.0,7/42,10.62%,MOXD1;LOXL3;LACC1;PAM;CUTA;ACR;CUTC
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3591079264577796,1.1465323789121704,0.25636942675159236,0.6581774750708609,1.0,16/60,9.85%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;KIT;ROR1;EPHA1;PDGFRB;TGFBR2;EPHA4;MST1R;MUSK
prerank,metalloendopeptidase activity (GO:0004222),0.3380222843793825,1.144522223206349,0.24702380952380953,0.6593957954950309,1.0,13/76,12.02%,ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;THSD4;MMP14;PMPCB;NLN;ADAM19;PAPLN
prerank,cAMP binding (GO:0030552),-0.4815059694858294,-1.1391964041257152,0.32448979591836735,0.6541822520907907,1.0,6/11,9.24%,PDE4D;PDE4B;HCN1;PDE10A;RAPGEF2;PDE2A
prerank,kinase binding (GO:0019900),-0.23924566498912858,-1.1360349094225504,0.05343511450381679,0.6574294193226959,1.0,109/434,16.72%,FRMD5;DLG2;UNC5C;SLC12A7;SLC12A2;PTPRJ;PTPRK;PLCG2;PDE8A;BCAR3;TFRC;ACSL3;CSPG4;CIT;ACTB;RPS19;TIAM1;NSF;NBEA;CADPS;ACVRL1;UTRN;CALM1;CALM2;LRBA;EMP2;RPS6;RPS3;ESR1;RPS7;EEF1A1;DAB2IP;CTNNB1;ACTA2;HDAC7;HSP90AB1;CEP68;CALM3;RCC2;EEF2;WWC1;HNRNPA0;CEACAM1;CNTLN;RAD23A;SMCR8;RHOB;PIK3IP1;SIK1;NPM1;RFFL;SYN1;CCND1;FAS;TRIM68;TRIP6;TTC28;SNAP91;CNKSR2;INKA2;SPRED2;DVL1;RHOG;SMAD1;BORA;CAV2;POLA1;NEFH;BARD1;NBEAL2;ANKRA2;TBC1D14;BCAR1;ARHGEF7;EGFR;ATF4;JTB;USF1;SRCIN1;CEP43;CAV1;WDCP;CASP9;RAC1;USP37;RGCC;PRKRIP1;PPP1CC;RHOH;PGAM1;PARK7;PTPRC;SHC4;VDAC1;CDKN1A;NEK9;NR4A3;CYLD;MAPT;IRGM;LYST;NOD2;PLCG1;MYOM1;SPRED3;IBTK;VRK1;AP1B1;BTG1
prerank,sulfotransferase activity (GO:0008146),0.38693015180459955,1.1350298994521044,0.28650646950092423,0.6803164581230469,1.0,3/33,4.64%,UST;CHST15;TPST1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.32854874235778764,-1.1350006428001036,0.2584856396866841,0.6549408119688345,1.0,12/46,15.97%,MGAT5;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;PIGQ;MGAT4A;GCNT1;B3GNT9;POMGNT2
prerank,lipase activity (GO:0016298),0.36616281373519066,1.1310628602897257,0.2899022801302932,0.6869862619208514,1.0,2/43,1.31%,PLA1A;SMPD3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.490621299056477,1.130968907550434,0.3264887063655031,0.6831780769131752,1.0,3/12,9.81%,SLC19A1;SLC17A9;SLC25A24
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.349353024189835,-1.1290522427991672,0.2832512315270936,0.6656310695702314,1.0,6/34,7.21%,MYO10;CYTH3;ARAP2;ARAP3;HIP1R;AKT1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4775586570578163,1.1286686589395123,0.3406998158379374,0.6848122203355097,1.0,4/13,6.11%,PDGFRA;ITGA5;VEGFD;PDGFRB
prerank,acid-thiol ligase activity (GO:0016878),0.48863212406916223,1.128658445418118,0.3302411873840445,0.6808824986264478,1.0,4/13,17.44%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.49857411990220085,1.1281733388875308,0.3264887063655031,0.6782034023909469,1.0,3/11,9.81%,SLC19A1;SLC17A9;SLC25A24
prerank,calcium ion binding (GO:0005509),0.2800845578927407,1.1278426877992493,0.20124223602484473,0.675191377725292,1.0,50/323,11.81%,ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;PLA2G4A;ENPP1;MICU1;CLEC3B;CEMIP2;PRF1;S100A6;ANXA2;CDH5;FBLN1;AMY1C;AMY1B;AMY1A;RCN1;ANXA3;S100A10;ANXA1;ADGRV1;PAM;ANXA11;CPNE1;ANXA4;PLA2G4C;CRP;THBS3;GLCE;ESYT1;ANXA5;DCHS1;PCDHB8;ANXA7;DSC3;DSC2;PLSCR4;SLC25A24;TPM4;STIM2;ENPP2;CDH13;PLSCR2;IHH;NUCB2;PPP3CB
prerank,adrenergic receptor binding (GO:0031690),-0.41696416732681996,-1.1256064635494056,0.2854077253218884,0.6699583248452288,1.0,7/16,24.13%,PDE4D;GNAS;RAPGEF2;AKAP5;C1QBP;ADRB1;APLP1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4209164745409332,1.1248662033497807,0.34363636363636363,0.6793471835392938,1.0,7/20,20.04%,AGPAT4;MOGAT3;AGPAT3;DGAT2;LPGAT1;ABHD5;DGAT1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4437667555983389,1.11772360752951,0.33771106941838647,0.6930204729365006,1.0,2/17,9.45%,CMPK2;AK5
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.5004168124653043,1.1172412512513616,0.3486590038314176,0.6903110515262678,1.0,3/10,10.66%,SLC6A13;SLC6A12;SLC10A1
prerank,protein kinase inhibitor activity (GO:0004860),-0.3275054391503411,-1.1158069970005844,0.27393617021276595,0.6913729528737624,1.0,15/42,19.56%,CIT;SNCA;SMCR8;NPM1;SH3BP5L;MAPK8IP1;INKA2;SPRED2;RACK1;CEP43;PRKRIP1;CDKN1A;IBTK;CDKN1C;SPRED1
prerank,CoA hydrolase activity (GO:0016289),0.45391117681180715,1.1155602203667345,0.33962264150943394,0.690575247421108,1.0,3/16,9.97%,ACOT11;ACOT9;ACOT1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.3305733677221093,-1.1094771738477125,0.2727272727272727,0.7028434359041645,1.0,6/37,9.86%,CACNA1E;CACNB2;CACNB4;OPRM1;CACNA1G;CACNA1D
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.40017606527753713,-1.1088813320432707,0.31752577319587627,0.6990597629208491,1.0,4/18,6.99%,PIK3R1;PIK3R6;PIK3R3;WDR81
prerank,cation channel activity (GO:0005261),0.31275731375177973,1.1081281315730258,0.2732732732732733,0.7057641696916548,1.0,18/94,11.64%,TRPM3;MCU;TRPM6;NALCN;ANXA2;KCNQ4;SLC24A3;P2RX1;TMEM38A;SLC4A11;ANO10;CALHM2;OTOP1;PKD1L3;PANX1;TRPC1;ANO6;GRIN3B
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3016922006479715,1.1068492763630724,0.26933701657458564,0.7053194608823651,1.0,15/134,5.94%,PDPN;SLC7A2;SLC1A3;SLC13A3;SLC6A13;SLC16A11;GJA1;SLC19A1;SLC6A9;SLC26A9;SLC16A12;SLCO3A1;SLC17A9;SLC35D1;SLC4A11
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.46992623095108493,-1.1061485723609066,0.3380855397148676,0.7010423436677057,1.0,5/10,19.24%,PIK3C2B;PIK3R3;ATM;PIK3CD;PIK3C3
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.37951844576823596,1.1047321397688536,0.3338842975206612,0.7068131654582367,1.0,15/34,26.95%,NSD3;METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;SETDB1;KMT5B;SMYD3;EHMT2;SUV39H1;SETD6;EEF1AKMT4;SMYD2
prerank,E-box binding (GO:0070888),0.3749830670177429,1.1040627161402643,0.30122591943957966,0.7046890680444741,1.0,1/34,0.06%,TCF4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.39911206612924666,1.103463259704914,0.33391003460207613,0.7021936710148285,1.0,6/26,4.55%,SLC6A13;SLC16A11;SLC16A2;SLC16A12;SLC6A12;SLC16A5
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.33831541880252364,1.102461227895586,0.3056,0.7011545669278137,1.0,16/60,17.03%,LRRK1;CTDSPL;PPM1E;PPM1A;MTMR3;PPEF2;CTDSP2;LRRK2;PPM1B;PPP1CB;CDC14A;PPP3CB;PPM1M;CTDSP1;PPP2CA;CDKN3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4779031456190936,1.098948291685031,0.3511586452762923,0.7062620969047917,1.0,2/11,8.12%,SASH1;PPEF2
prerank,protein kinase binding (GO:0019901),-0.2253139726669343,-1.0989220461254001,0.125,0.715778196147948,1.0,117/479,16.53%,FRMD5;UNC5C;SLC12A7;SLC12A2;PTPRJ;PTPRK;PRKCB;PLCG2;GRM5;PDE3B;BMPR2;TFRC;ACSL3;RYR2;CSPG4;CIT;ACTB;RPS19;NSF;NBEA;CADPS;ACVRL1;UTRN;CALM1;CALM2;LRBA;EMP2;RPS6;RPS3;ESR1;RPS7;EEF1A1;DAB2IP;NELL2;PKN1;HINT1;PRKAR1A;ACTA2;HDAC7;HDAC9;CEP68;CCDC88A;CALM3;TCF3;RCC2;EEF2;MAP3K11;ACE;HNRNPA0;CEACAM1;CNTLN;SMCR8;RHOB;SIK1;PINK1;NPM1;RFFL;SYN1;CCND1;TRIM68;DUSP22;SNAP91;CNKSR2;INKA2;SPRED2;DVL1;DUSP8;GCH1;RHOG;RACK1;SMAD1;BORA;CAV2;POLA1;NEFH;NBEAL2;ANKRA2;TBC1D14;BCAR1;PRKAR2B;ARHGEF7;KCNQ1;ATF4;JTB;USF1;SRCIN1;ACVR1;HSP90AA1;CEP43;CAV1;CAVIN2;MAPK8IP3;CASP9;RAC1;USP37;RGCC;PRKRIP1;PPP1CC;RHOH;TJP2;PGAM1;PTPRC;SHC4;VDAC1;CDKN1A;NEK9;NR4A3;CYLD;MAPT;IRGM;LYST;NOD2;PLCG1;SPRED3;IBTK;VRK1;AP1B1
prerank,RNA binding (GO:0003723),-0.21275380461555993,-1.0982295397734503,0.0,0.7121658367942305,1.0,364/1321,22.83%,SORBS2;SYNE1;RIMS1;STRBP;NOL4;RPS24;ACTN1;TMSB4X;RALYL;QKI;HSPA8;LRRFIP1;TCF20;RPS9;RPL18A;TFRC;RPL19;TPT1;RFTN1;CMSS1;NOVA2;FAU;RPS12;ADARB1;RPL26;RPL41;RPS15;RPL24;RPS23;MBNL1;CELF4;RPL5;KHDRBS2;RPS27;RPS19;RPL38;RBFOX3;LIN28B;RBFOX1;SCG3;PUS7;RPS8;SETX;RPL10A;RPL27A;RPL13;LUC7L3;CSTF2;RPS18;MACF1;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;R3HDM1;ELAVL2;RPL39;RPS17;ATXN2;RPS7;RPL37A;KIF1C;RPL4;RPS25;EEF1A1;PTBP1;CPEB2;RPS15A;ELP1;CEBPZ;RPL6;ADARB2;RPL11;RPLP0;RPS21;RPS28;RPL28;TAF15;RPL32;RPL8;HMGB1;PUF60;KHDRBS3;STXBP1;SCAF4;PKM;RPL13A;RPL30;DHX15;SRP14;SRSF2;HSP90AB1;YBX1;ATP5F1A;RPS20;RPS4X;ZFR2;GTPBP1;MRPL4;RPL18;KPNB1;RPS13;TES;CPSF2;NOL11;RCC2;EEF2;MTCL1;UNK;RPS2;RRP7A;SRSF1;APOBEC1;ZCRB1;HNRNPA0;PHF6;CNBP;MYEF2;DDX54;HNRNPK;RPL14;DDX49;RPL22;PCBP1;TIAL1;DDX11;PUM3;HNRNPH2;SSRP1;ZC3H11A;PPIL4;NPM1;YTHDF2;SREK1;DDX47;DYNC1H1;WDR36;DDX17;TRA2A;THOC2;SART3;FAM32A;YY1;DNTTIP2;BUD13;GFM1;KCTD12;MAP3K20;HSPE1;RPS26;TRIP6;CALR;NKAP;BYSL;KARS1;GNL3L;RO60;CCAR2;DHX30;YTHDC2;CARS1;RACK1;GDI2;PSMD4;NELFCD;MAK16;MANF;RPS10;NOL12;IGHMBP2;EXOSC2;NIP7;EIF5B;RALY;NVL;EIF4A1;BARD1;FTSJ3;RPL23;RPL17;PSMA6;PTCD2;PABPC4;EIF1B;EIF5A;WBP11;FKBP3;RPL29;MRPL1;PABPC4L;H1-0;THUMPD1;RPP30;S100A16;HSP90AA1;MRPS30;GSPT2;EIF3A;MRPS23;RPL22L1;RPS5;ELP5;PPAN;GRN;FASTKD2;RPS14;SLC3A2;NOP56;SNRNP35;DCP1A;PRKRIP1;LSM14B;ACTN4;PPP1CC;RAE1;SART1;TUBB4B;PPRC1;SNRPB;DBR1;ANP32A;VIRMA;MSI2;FAM120C;PPIA;PARK7;HNRNPF;XPOT;AKAP1;MRM1;CCDC47;CPEB4;RARS2;TUBA1B;ZC3H13;MAPT;HMGN2;ZGRF1;SRBD1;MTPAP;SRP9;ZMAT3;ENO1;MRPL28;RPL12;ZCCHC3;NOL7;NUDT16L1;MYO18A;CSTF2T;ADD1;RBM33;RPL9;SMNDC1;ESF1;FRG1;DDX51;UBE2O;RBM3;XRN2;BRCA1;RPS19BP1;RPL37;IMP3;RBM19;GNL3;ERI1;LUC7L;RPS11;CS;EIF1;PPIB;DUSP11;HSD17B10;MEX3A;DICER1;RNPS1;PABPC1;LGALS1;LLPH;N4BP1;SNRPF;CCDC9;TRIM28;SRSF9;SNU13;RAVER2;YRDC;POLDIP3;FKBP4;MRPS5;RIDA;ZCCHC8;NOC2L;NONO;RPL7;RPL31;RPL7A;C1QBP;MKRN1;EWSR1;UTP6;EIF3H;TYW5;RBM15B;RBM47;EIF4A2;WRAP53;EIF3G;PPP1R10;SAFB2;TRMT6;BMS1;YARS2;RTCA;UPF1;PURB;LSM4;FAM98A;MKI67;ALKBH5;RPL3;BAG4;SNRPD1;SNRPD2;NANOS3;MEX3D;HNRNPLL;HEATR1;DHX35;UTP11;TFB2M;TRMT9B;MRPL23;MRPL9;FAM50A;FBRSL1;MDH2;ZC3H8;SRSF6;CAPRIN1;SF3B5;CELF6;GSPT1;CHTOP;NKRF;FASN;MCAT;TFB1M;CPSF3;MRPS31;HEXIM2;TOE1;WDR46;FLYWCH2;HDGF;SRF;MRPS12;RPL23A;SYF2;YWHAZ;TUFM
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4805642098557076,1.095847292035031,0.3629032258064516,0.7104485095121201,1.0,3/12,11.18%,TRAF5;STAT1;TRAP1
prerank,epidermal growth factor receptor binding (GO:0005154),0.40137539156673774,1.0901113290691453,0.35126050420168065,0.721548896350046,1.0,4/25,6.06%,EFEMP1;FER;TGFA;ARF4
prerank,metal ion binding (GO:0046872),0.2629737937775541,1.0891672939093278,0.24611708482676226,0.7203031438006362,1.0,76/477,13.28%,EYA2;IGFBP3;ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;PLA2G4A;ENPP1;MICU1;OXSR1;CLEC3B;TSSK3;CEMIP2;PRF1;DCTPP1;S100A6;CLYBL;ANXA2;CDH5;FBLN1;AMY1C;AMY1B;AMY1A;RCN1;ANXA3;S100A10;ANXA1;ADGRV1;WRN;PAM;ANXA11;PIR;CPNE1;IDH1;TESMIN;ANXA4;PLA2G4C;CRP;THBS3;PAPOLG;GLCE;ESYT1;ANXA5;DCHS1;PCDHB8;ANXA7;STK3;SIK3;PDXK;LRRK2;DSC3;DSC2;PLSCR4;SLC25A24;TPM4;STIM2;GEM;ENPP2;HACL1;CDH13;PLSCR2;IRAK3;ADPRS;IHH;NUCB2;PPP3CB;CRNN;TRIM26;OPA1;SRPK1;IDH2;SMOC2;BAIAP3
prerank,vinculin binding (GO:0017166),-0.4525517900178076,-1.0891141584790471,0.35234215885947046,0.7319483360065617,1.0,3/11,3.65%,ACTN1;DMD;UTRN
prerank,metallopeptidase activity (GO:0008237),0.3038803206239572,1.0887163537667672,0.2989985693848355,0.7176892662545874,1.0,22/113,14.02%,ADAMTSL5;PAPPA;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;ANPEP;BMP1;THSD4;MMP14;ADAM12;ERAP1;MYSM1;PMPCB;NLN;ADAM19;PAPLN;RNPEP;ADAMTS7;LNPEP
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.44854952893205796,1.0856485171932226,0.37057728119180633,0.7223995667606086,1.0,4/14,8.35%,COL4A3;TIMP3;BST2;TIMP2
prerank,acetyltransferase activity (GO:0016407),0.37625469412076057,1.084774880782662,0.3473684210526316,0.720863378191186,1.0,10/31,16.97%,CREBBP;KAT6B;NAA16;PAFAH1B3;ESCO1;ACAT1;NAA15;KAT6A;KAT2B;PAFAH2
prerank,microtubule binding (GO:0008017),-0.2397561885310098,-1.0822997217550212,0.2186046511627907,0.7449724696820709,1.0,50/222,17.80%,DNM3;MTUS1;SGIP1;SYBU;NAV3;MID1;KIF1B;EML6;REEP1;KIF26B;MACF1;KIF21A;RPS3;KIF1C;FMN1;RP1;STARD9;ARHGEF2;CRIPT;MID2;CCDC88A;RCC2;MTCL1;MAP1B;TERF1;HDAC6;SNPH;KIF26A;KIF18A;NEFH;FGF13;KIF5C;KIF15;KIF3B;NDE1;CLASP2;RAE1;KIF16B;KIF5A;MAPT;CLIP2;KRIT1;MAP2;SKA2;CEP290;CCDC69;GAS2L3;PRC1;KIF27;TPPP
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.40848657134660393,-1.0807894470236286,0.3473193473193473,0.7440321943096257,1.0,2/14,1.62%,SLC26A7;SLC26A2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.4037543259689351,-1.0797107687662892,0.3622222222222222,0.7415785985619746,1.0,8/15,30.33%,COX4I1;COX8A;NDUFA4;COX6A1;NDUFA4L2;CYB5A;COX4I2;COX5B
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3794736918008891,-1.0759339811559958,0.34518828451882844,0.7470278360516313,1.0,5/21,20.27%,GRM5;GRIA1;CHRNA4;CHRFAM7A;CHRNA7
prerank,methylated histone binding (GO:0035064),0.32259526209978184,1.0756212989804077,0.34762633996937214,0.7407131014273888,1.0,25/62,24.70%,KDM7A;SUZ12;MORC3;DPF2;TRIM24;ZMYND11;GLYR1;TAF7;RRP8;BPTF;MORC4;KDM8;PYGO1;LRWD1;CHD8;MBTD1;MPHOSPH8;PHF1;PHF13;PHF8;ZCWPW1;TAF1;WDR5;ING5;ATRX
prerank,potassium:proton antiporter activity (GO:0015386),-0.4660640982383477,-1.0748641768016225,0.36477987421383645,0.7445588685142687,1.0,3/10,14.68%,SLC9A2;SLC9A8;SLC9A5
prerank,solute:sodium symporter activity (GO:0015370),-0.3507097568203815,-1.0739797289009985,0.3424036281179138,0.7416902253227544,1.0,9/27,32.62%,SLC4A10;SLC5A6;SLC4A7;SLC20A2;SLC5A11;SLC13A5;SLC5A3;SLC4A4;SLC4A5
prerank,ion channel inhibitor activity (GO:0008200),-0.3334305323060353,-1.0738365589738343,0.33886255924170616,0.7368101267321283,1.0,9/35,10.38%,KCNMB2;FKBP1A;MCUB;CALM1;CALM2;CAMK2D;SLC30A1;NEDD4L;RACK1
prerank,CoA-ligase activity (GO:0016405),0.46024184293728204,1.0738172443957898,0.3802559414990859,0.741593780698773,1.0,4/14,17.44%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,tau-protein kinase activity (GO:0050321),0.4080903452072307,1.0726870137695075,0.37122557726465366,0.7406608026520878,1.0,3/20,8.65%,ROCK2;GSK3B;SIK3
prerank,transferrin receptor binding (GO:1990459),0.4802175699033532,1.0698944074925612,0.38551859099804303,0.7442918218014822,1.0,2/10,12.58%,RGMA;HFE
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.37006390673944267,1.069321950670983,0.3769363166953528,0.7419619086549375,1.0,3/35,2.99%,TEC;STYK1;FER
prerank,aminopeptidase activity (GO:0004177),0.39156221912885036,1.0687931923276084,0.3641304347826087,0.7395149540142179,1.0,9/26,14.11%,ANPEP;MMP14;NPEPPS;CTSH;ERAP1;BLMH;RNPEP;LNPEP;KDM8
prerank,"DNA binding, bending (GO:0008301)",0.44810326843907944,1.067253398309358,0.38247011952191234,0.7399449318073931,1.0,2/14,1.80%,FOXD1;FOXC1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2657127285185145,1.0644241020186374,0.31912144702842377,0.7437355467027423,1.0,39/254,13.51%,TCF4;SMAD3;RBPJ;ELF1;FOXC1;NFIA;NFYC;NFAT5;SPIB;ZNF395;FOXC2;MYB;HOXC4;LITAF;HLF;PRRX1;TCF12;KLF5;CREB3L3;PPARA;GLIS2;CREBRF;ZSCAN21;MEF2A;RLF;ELF4;E4F1;RFXANK;RFXAP;SMAD4;FOXO3;NR4A1;EGR2;HOXA10;NFIC;MZF1;NR3C1;GMEB1;NRF1
prerank,zinc ion binding (GO:0008270),0.26285181866682744,1.064201089874115,0.3191747572815534,0.7406239005952352,1.0,55/293,14.53%,KMT2A;ENPP3;CBLB;SMAD3;ENPP1;PAPPA;KDM7A;SHMT1;RC3H1;LITAF;UBA5;ANPEP;SEC23A;MYCBP2;PAM;ZNF3;CSRP1;HDAC4;NPEPPS;NSD1;SEC24D;GLO1;TRIM24;SKI;ZMYND11;TIMP2;BAZ1B;ZFP37;ZEB1;ACR;PDXK;SLU7;MNAT1;QPCTL;ERAP1;ENPP2;ESCO1;SEC24C;ZCCHC4;FNTB;KDM5B;NQO2;EEA1;THAP1;PTPN1;KDM2A;TET2;TIMM9;RNPEP;ZNF205;KAT6A;LNPEP;MDM4;IFIH1;RCHY1
prerank,cytokine receptor activity (GO:0004896),0.3071074189405539,1.0635029825295803,0.37058823529411766,0.7386896915458216,1.0,6/83,2.40%,LEPR;GHR;IL31RA;IL6ST;ACKR2;CCR9
prerank,phospholipase A2 activity (GO:0004623),0.3773612866717266,1.0585731159061926,0.39316239316239315,0.7476848564573633,1.0,3/26,8.09%,PLA2G4A;PLA2G4C;PLA2G6
prerank,protein phosphatase binding (GO:0019903),-0.2580992813841776,-1.0574973388809565,0.32094594594594594,0.7763177707349059,1.0,24/117,16.20%,PPP1R16B;GRIN3A;FOXO1;PIK3R1;PHACTR4;MAP3K5;PPP1R3B;MET;DAB2IP;CTNNB1;SNX3;FBXL2;CEACAM1;MFHAS1;PPP1R11;PTPRT;RACK1;EGFR;KCNQ1;SOD1;MYO16;MAPT;PPP1R3C;ADCY8
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3312577728127902,1.056096011418573,0.36807817589576547,0.7504568441474488,1.0,6/49,6.54%,MPPED2;ATP1A2;DUSP10;DUSP28;PTPN22;DUSP16
prerank,protein kinase C binding (GO:0005080),0.3381669767837421,1.0549285042272547,0.38421955403087477,0.7496570694481993,1.0,12/43,15.77%,PRKCSH;NELL1;PARD6G;DACT1;PARD6A;TOP2B;PLEK;GRK5;DACT2;CAVIN3;ADCY6;PRKD2
prerank,histone methyltransferase activity (GO:0042054),0.360992730298333,1.0545908861179294,0.3996655518394649,0.7468962160717916,1.0,13/32,26.95%,SUZ12;KMT2C;NSD3;SETD7;CARM1;SETD2;SETDB1;KMT5B;SMYD3;PRMT1;EHMT2;SUV39H1;SMYD2
prerank,dynactin binding (GO:0034452),0.4512078887292382,1.0544410305243308,0.4198473282442748,0.7437202274145391,1.0,2/12,7.66%,SNX6;GSK3B
prerank,protein homodimerization activity (GO:0042803),0.24980608509904587,1.0512262820888383,0.3355408388520971,0.7479777529467162,1.0,110/589,15.78%,KMT2A;TNNC1;DPP4;SMAD3;NADK2;ZHX2;NR2F2;PDGFRA;FGFR1;MTUS2;MAPK4;ENPP1;GHR;CPQ;GBP2;APOA2;SHMT1;ZBTB4;BMPR1A;NR6A1;S100A6;SNX6;GLIPR2;HSD17B1;DGKD;S100A10;AOX1;KIT;TERT;WRN;IL17D;UBA5;CRYL1;EFEMP2;FECH;TPST1;ARNT;BCL2;TPM1;RDH5;MCL1;APPL2;TPR;IDH1;ZDHHC3;CREB3L3;FOXP3;TRIM5;GBP5;BST2;NOS2;DPYD;GBP4;GYG1;SPPL3;GLCE;STAT1;GOLGA5;RIPK2;SNX9;EXD1;PHB2;BAX;PDXK;LRRK2;APPL1;TPM4;FBXO4;PLEK;PAFAH1B3;DNM1L;BCL2L1;IRAK3;SMAD4;CSF1;DGAT2;TRIM21;NQO2;EEA1;ABCD3;THAP1;NOG;RAP1GAP;MAP3K13;PGRMC1;SUPV3L1;PON3;MZF1;BHLHE41;CCDC66;NPR3;NRF1;SDCBP2;PIP4K2B;ADRA2C;TIMM9;CIB2;ERCC5;TARBP2;RCHY1;PML;GDF15;CHMP4A;CHMP4B;ADRA2A;CUBN;STK4;HSPB6;FLRT3;PKD2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4318377342863413,-1.0493459468884994,0.4031620553359684,0.793933168899559,1.0,6/12,20.73%,NOD1;ATP2A3;RACK1;PYCARD;CASP1;BAD
prerank,myosin II binding (GO:0045159),-0.44192193896919385,-1.047985381756295,0.3911290322580645,0.7922166328635473,1.0,3/10,10.73%,SHROOM4;STXBP5L;SHROOM1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4359938578716809,1.0420035968920414,0.43159922928709055,0.7678000547657405,1.0,2/14,10.33%,RSAD2;ACO1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.4064152690003351,-1.0402116774632326,0.41914893617021276,0.8092109074349658,1.0,4/13,12.24%,RYR2;PRKAR1A;PRKAR2B;KCNQ1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2592087239135565,-1.0397959994839583,0.3902439024390244,0.8049512507963738,1.0,23/91,15.71%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;SNX3;CLVS1;KCNH1;SDCBP;SYT7;STXBP6;PLEKHA5;LDLRAP1;RAB35;SNAP91;MARK1;KCNQ1;AMER2;KIF16B;SNX18;MAPT;KRIT1;TWF1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3370031943364621,1.0396189449679263,0.4206219312602291,0.7704396592746507,1.0,7/44,11.07%,KMT2A;KMT2C;NSD3;NSD1;SETD4;SETD7;SETD1B
prerank,phosphatase activator activity (GO:0019211),-0.4004104594143477,-1.0392689474197807,0.4122448979591837,0.8009018683037487,1.0,9/14,24.29%,PHACTR4;CALM1;CALM2;CALM3;PPP2R5B;PPP2R5D;PPP1R15A;PPP2R5A;B3GAT3
prerank,endopeptidase activator activity (GO:0061133),-0.4482398055506558,-1.0377229799602687,0.4376237623762376,0.7997196054040787,1.0,4/10,26.69%,PSMD14;PSENEN;PSME1;NLRC4
prerank,cyclic nucleotide binding (GO:0030551),0.3911558864713657,1.0372147155737508,0.4406779661016949,0.7731955812195276,1.0,5/21,6.53%,RAPGEF4;PDE5A;SLC19A1;POPDC2;CNBD2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3523179956447816,-1.0366186559609887,0.41418764302059496,0.7973611738808323,1.0,8/24,17.26%,RPL26;RPL41;RPL5;RPS7;RPS13;RPS14;GNL3;CCT5
prerank,potassium ion antiporter activity (GO:0022821),-0.39331570480485945,-1.0366096324232033,0.4107142857142857,0.7920368227590378,1.0,3/15,6.32%,SLC9A2;SLC24A2;SLC9A8
prerank,alpha-actinin binding (GO:0051393),0.3698669491517577,1.0355764047366962,0.4006908462867012,0.7736747727304458,1.0,7/24,17.91%,DAG1;SYNPO2;PRICKLE4;CACNA1C;RARA;PKD2;PDLIM2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3044377168250396,1.033163772976277,0.410459587955626,0.7763522930752568,1.0,13/74,10.06%,NADK2;FAM20C;FAM20A;DGKD;HYKK;PI4KA;PANK2;PIK3C2A;FAM20B;GALK2;PDXK;GK5;TRPT1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4459907105847855,1.0326312709081473,0.3988549618320611,0.7741923620188559,1.0,3/12,3.32%,CDH5;ITGA5;VEGFD
prerank,lysophospholipase activity (GO:0004622),0.3927589401394307,1.0305668771124405,0.4230088495575221,0.775954837557984,1.0,4/20,10.74%,PLA2G4A;PLA2G4C;PLA2G6;ENPP2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3454499391162376,-1.0299984963275604,0.39461883408071746,0.8051060754111983,1.0,5/23,8.81%,HIP1;HIP1R;SNX3;CLVS1;PLEKHA5
prerank,protein phosphatase 2A binding (GO:0051721),-0.35032162073196405,-1.0283018979432832,0.41299303944315546,0.804741871947698,1.0,6/23,16.20%,GRIN3A;FOXO1;DAB2IP;MFHAS1;MAPT;ADCY8
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3753779926124798,1.0282764805021853,0.4388111888111888,0.7785570011275019,1.0,4/25,6.27%,PLEKHA2;GAB2;ADAP2;PLEKHA4
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.45720844476306344,1.0261798284288808,0.4350515463917526,0.7766810389073577,1.0,3/10,12.11%,DUSP10;DUSP16;DUSP5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.45720844476306344,1.0261798284288808,0.4350515463917526,0.7766810389073577,1.0,3/10,12.11%,DUSP10;DUSP16;DUSP5
prerank,guanyl ribonucleotide binding (GO:0032561),0.26337026566096067,1.0256991368366108,0.4177545691906005,0.7743510412237373,1.0,50/196,19.74%,MPPED2;GBP6;PDE5A;GBP2;RRAS2;SLC19A1;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;RRAD;RHOQ;LRRK2;ARF3;RAP2C;GEM;RABL6;GBP7;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;MIEF1;TUBB2B;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;ARF1;RAN;RAP2B;LSG1;GNAI3;RHOT1;RANBP17;ARL6;DIRAS1;RHOT2;ARFIP2;NRAS
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.42640517436365827,-1.025494512882929,0.4368932038834951,0.8073009753763494,1.0,2/11,4.80%,LEF1;GATA2
prerank,endoribonuclease activity (GO:0004521),0.35276866311266114,1.0245204523493516,0.4068100358422939,0.7737095567576235,1.0,12/32,23.42%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;SLFN14;ZC3H12B;ERN2;RNASEL;YBEY;ZC3H12A;KHNYN
prerank,ribosomal small subunit binding (GO:0043024),-0.3719434808579474,-1.0235398064379189,0.41561181434599154,0.8078299670114287,1.0,9/17,37.27%,CPEB2;NPM1;EIF1B;EIF1;PIM1;ERAL1;DHX29;MTIF2;UNG
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.29894812742720867,1.0209114244979296,0.41878980891719747,0.7790203229118744,1.0,11/75,8.95%,SDR9C7;RDH10;LDHAL6B;PHGDH;PGD;CRYL1;RDH5;ME2;PTGR1;DHDH;GLYR1
prerank,tau protein binding (GO:0048156),-0.29786706254208367,-1.0178829059452155,0.42891566265060244,0.8183753088507923,1.0,11/40,15.98%,ACTB;SNCA;S100B;HSP90AB1;LGMN;HDAC6;MARK1;TTBK1;HSP90AA1;BRSK2;MAP2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3573630224490939,-1.0170360678505967,0.4298245614035088,0.8153915946435447,1.0,5/19,9.11%,RYR2;GRIN2A;RYR3;GRIN2B;GRIN1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.35287008178560314,1.0164121522677059,0.431858407079646,0.7869564945121963,1.0,14/29,23.43%,DUSP10;TPR;DUSP16;ATF7;MAPK14;DUSP5;MAPKAPK5;MAPKAPK3;DIRAS1;TNIP1;MAPK7;CDK5RAP3;PRMT1;DUSP4
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.43669374279399076,1.013770615891529,0.4629294755877034,0.7902790667291105,1.0,3/12,11.59%,GAB2;FRS2;SH2B3
prerank,NF-kappaB binding (GO:0051059),0.3751701953350617,1.012674177322328,0.41796200345423146,0.7895557409580471,1.0,5/24,7.66%,MTDH;CPNE1;FOXP3;ANXA4;GSK3B
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.405551074332569,-1.0113802034932013,0.4524793388429752,0.826121653772273,1.0,6/12,31.60%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,snoRNA binding (GO:0030515),-0.32308325906343105,-1.0105998651064438,0.43364928909952605,0.8229018477629572,1.0,15/30,35.68%,BYSL;NOP56;NUDT16L1;IMP3;SNU13;UTP6;BMS1;HEATR1;IMP4;NUDT16;NOP10;PRKDC;NHP2;NUDT1;DHX37
prerank,beta-tubulin binding (GO:0048487),0.355639465014558,1.0097596999544498,0.4433164128595601,0.793212765657064,1.0,6/31,9.79%,GJB6;DLEC1;UXT;EML4;PDCD5;APPL1
prerank,phosphate ion binding (GO:0042301),-0.4347225200700149,-1.009336847119297,0.46368715083798884,0.8211713090425159,1.0,5/10,29.64%,PDE2A;PNP;ADSS2;ADSS1;RELA
prerank,retinoic acid receptor binding (GO:0042974),0.39909797237891914,1.0088251871448328,0.4670138888888889,0.7918758597434461,1.0,3/17,6.89%,NCOA6;TACC1;NSD1
prerank,MAP kinase phosphatase activity (GO:0033549),0.42697477098184206,1.0087186862561026,0.4396039603960396,0.7886414120359707,1.0,3/12,12.11%,DUSP10;DUSP16;DUSP5
prerank,mechanosensitive ion channel activity (GO:0008381),-0.40801470898098363,-1.0084270092442449,0.46041666666666664,0.8186255301034389,1.0,1/12,0.51%,PIEZO2
prerank,phosphotyrosine residue binding (GO:0001784),-0.30969452221382665,-1.0077214682273412,0.4,0.8152545913452408,1.0,14/37,24.78%,PLCG2;BCAR3;PIK3R1;SHE;PIK3R3;LDLRAP1;VAV1;SYK;PTPN5;SHD;IRS1;SAMSN1;SHC3;PFN1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.36196967308012173,1.0068902184207107,0.45195729537366547,0.789926104753861,1.0,5/25,6.49%,MICAL3;CYP27A1;POR;FMO5;NOS2
prerank,TBP-class protein binding (GO:0017025),-0.34528835569267313,-1.0066958011039162,0.4657534246575342,0.8130276747844865,1.0,11/21,38.56%,ESR1;HHEX;TAF11;PSMC5;GTF2A2;TAF1B;RUVBL2;THRA;GTF2B;PSMC1;YEATS2
prerank,cGMP binding (GO:0030553),-0.4230339069426764,-1.0066554459912693,0.4649805447470817,0.808158350498167,1.0,4/11,9.24%,PDE11A;PDE10A;RAPGEF2;PDE2A
prerank,protein phosphatase activator activity (GO:0072542),0.4270854849885066,1.0050592178029152,0.4661508704061896,0.7911952365181735,1.0,1/13,0.16%,IGFBP3
prerank,peptidoglycan binding (GO:0042834),-0.4334565798060003,-1.004912462467933,0.4656964656964657,0.8079444972965832,1.0,4/10,15.58%,NOD1;PGLYRP1;RNASE7;NOD2
prerank,U6 snRNA binding (GO:0017070),-0.39442653358000745,-1.003137967409766,0.43775933609958506,0.8077947285354679,1.0,7/14,30.83%,SART3;EIF5A;LSM4;LSM2;LSM3;LSM8;PRPF8
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4300538912885744,1.0031030208821303,0.4591078066914498,0.7925700278723883,1.0,4/12,15.93%,TENT5A;PAPOLG;TENT2;PAPOLB
prerank,calcium-dependent phospholipid binding (GO:0005544),0.32057783962190545,1.000926641623676,0.4187604690117253,0.7942987006839375,1.0,9/49,7.88%,PLA2G4A;ANXA2;ANXA3;ANXA1;CPNE1;ANXA4;PLA2G4C;ESYT1;ANXA5
prerank,pyrophosphatase activity (GO:0016462),0.31934839568734863,1.0007546685008628,0.4588815789473684,0.7913291878833927,1.0,5/50,7.46%,ENPP3;ENPP1;DCTPP1;ENTPD7;DCP2
prerank,estrogen receptor binding (GO:0030331),-0.31419584812999773,-0.9998660988242045,0.4617169373549884,0.8116674111087498,1.0,5/32,7.65%,LEF1;RERG;ESR1;CTNNB1;DDX54
prerank,SH3 domain binding (GO:0017124),-0.2707664584544639,-0.9991052422668799,0.4441340782122905,0.8088975276080584,1.0,11/62,10.75%,AFAP1L1;SGIP1;SHANK3;ENAH;ELMO1;ADAM15;DAB2IP;ARHGAP27;ABI3;VASP;CBL
prerank,steroid hydroxylase activity (GO:0008395),0.4006453270780867,0.9983803960907344,0.463768115942029,0.7940381543213463,1.0,2/16,3.22%,CYP7B1;CYP27A1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.26486788078397877,0.9976067097157694,0.468232044198895,0.7926202302178624,1.0,34/173,16.65%,ZBTB20;ZEB2;MXI1;KCNIP3;ZBTB4;NFATC4;AEBP1;GZF1;OTP;ZNF3;FOXP3;PPARA;ZBTB37;SKI;ZNF25;ZFP37;ZEB1;CREM;E4F1;HEYL;FOXO3;ZNF219;THAP1;MZF1;BHLHE41;NR3C1;HIC1;PRDM5;ZBTB21;ZBTB12;POU5F1;JDP2;POU6F1;ZBTB5
prerank,metalloaminopeptidase activity (GO:0070006),0.40833682546966926,0.9951853606182552,0.46716697936210133,0.7947634254312513,1.0,6/16,14.02%,ANPEP;MMP14;NPEPPS;ERAP1;RNPEP;LNPEP
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.37477635239649437,-0.9934280174411259,0.46756152125279643,0.8196358705999977,1.0,2/15,1.62%,SLC26A7;SLC26A2
prerank,DNA secondary structure binding (GO:0000217),0.34435265834687023,0.9909085781074563,0.47884940778341795,0.8021789478231425,1.0,6/31,14.03%,KMT2A;WRN;FANCM;RBBP8;RAD51B;ERCC5
prerank,ion gated channel activity (GO:0022839),-0.3292130145388738,-0.9888317029199108,0.47139588100686497,0.8274617846213139,1.0,9/24,15.36%,ANO1;ANO3;KCNT1;TMEM63C;ANO4;TTYH2;TTYH3;ANO2;TTYH1
prerank,phosphatase inhibitor activity (GO:0019212),0.37570144991271076,0.9852197816309167,0.4853700516351119,0.8122288915293638,1.0,8/20,24.31%,PTN;ANP32E;BOD1L1;URI1;STYX;STYXL1;PPP1R2;CABIN1
prerank,phosphatase binding (GO:0019902),0.27228386938926513,0.9816815052754987,0.4908321579689704,0.817645871739531,1.0,23/105,16.48%,SMAD3;CDH5;CRY2;CRY1;IKBKE;DZIP3;MTMR3;MVP;DLG1;MAPK14;PPP6R3;PTK2;SHOC2;JAK1;CDC27;CNST;WNK1;TBK1;EIF2AK3;SH3YL1;IQGAP1;SMAD2;NFATC2
prerank,sodium channel regulator activity (GO:0017080),-0.29628138380487556,-0.9809929364857441,0.5012468827930174,0.8436127778419416,1.0,18/37,29.86%,FGF14;FGF12;FXYD5;YWHAH;CAMK2D;NEDD4L;NOS1;FGF13;FXYD1;SCN2B;SCN1B;SGK1;SGK2;SGK3;PKP2;RANGRF;FGF11;FXYD6
prerank,endonuclease activity (GO:0004519),0.306718675287945,0.9805006091951947,0.4820846905537459,0.8172236153100679,1.0,12/49,15.81%,PIWIL4;NTHL1;NYNRIN;SND1;SMG6;ENDOU;OGG1;SLFN14;ERCC5;ZC3H12B;DIS3;ERN2
prerank,chloride channel inhibitor activity (GO:0019869),0.4262954537291606,0.9780248102517913,0.4869215291750503,0.8197415348087469,1.0,3/10,14.09%,WNK4;STX8;WNK1
prerank,general transcription initiation factor binding (GO:0140296),-0.3195473406825493,-0.9763233010905565,0.5070754716981132,0.8512767497157034,1.0,12/25,38.56%,ESR1;HHEX;TAF11;PSMC5;RELA;GTF2A2;TAF1B;RUVBL2;THRA;GTF2B;PSMC1;YEATS2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.43285254250878213,0.9753231933974896,0.4909456740442656,0.8230387667975235,1.0,3/10,10.41%,USP27X;STAMBP;STAMBPL1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.40190773883306563,-0.9729285605234648,0.48770491803278687,0.8555847063770032,1.0,4/11,6.77%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,methylation-dependent protein binding (GO:0140034),0.2994635906907913,0.9726252447529327,0.4944178628389155,0.8264730585109489,1.0,22/57,24.70%,KDM7A;SUZ12;MORC3;TRIM24;ZMYND11;GLYR1;RRP8;BPTF;MORC4;KDM8;PYGO1;LRWD1;CHD8;MBTD1;MPHOSPH8;PHF1;PHF13;PHF8;ZCWPW1;WDR5;ING5;ATRX
prerank,mannosyltransferase activity (GO:0000030),0.3650838485622181,0.9700268781164268,0.4763636363636364,0.8291672791385033,1.0,4/21,7.26%,TMTC4;TMTC1;ALG9;POMT2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4359455701830621,0.969806449415153,0.5009560229445507,0.8262823853290372,1.0,3/10,11.36%,NAA16;NAA30;NAA15
prerank,cardiolipin binding (GO:1901612),0.4485378705509697,0.9680051152352452,0.509090909090909,0.8275149991831732,1.0,4/10,25.30%,GSDME;OPA1;GSDMD;STOML2
prerank,carbohydrate kinase activity (GO:0019200),0.42069254855761096,0.9665439631893986,0.5311909262759924,0.8275212667742592,1.0,5/11,18.10%,GALK2;XYLB;KHK;HK1;NAGK
prerank,single-stranded DNA binding (GO:0003697),0.2754683378715505,0.9658176197592165,0.537890044576523,0.826030337335114,1.0,25/93,20.15%,RBMS1;SSBP2;POLR2D;CRY2;NUCKS1;TOP1;FBH1;NABP1;FUBP1;RPA3;MCM4;RTF1;RBBP8;MCM6;RAD51B;ERCC5;ERCC1;PCBP2;DHX36;XPC;TDP2;LONP1;SMC6;CTC1;NABP2
prerank,kinase activity (GO:0016301),-0.23561941002847744,-0.9654709072290021,0.5305466237942122,0.8714135867861952,1.0,30/109,19.24%,DGKB;DGKI;DGKH;ITPKB;PGK1;PIK3C2B;DGKZ;AKT1;PGM2L1;CAMK2A;RFK;PINK1;FN3K;IP6K2;LYN;ETNK1;BCKDK;PIK3CD;CERK;SEPHS1;DGKG;PPIP5K2;PRKD1;PPIP5K1;PANK1;CKB;FN3KRP;IRAK1;NADK;PIK3C3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2851862526662865,0.9617364718006189,0.5227272727272727,0.8323196304932295,1.0,21/78,18.30%,USP18;CASP12;CFLAR;CASP4;CTSH;USP24;USP9X;ESPL1;USP8;USP47;CTSW;CAPN15;USP40;USP35;USP34;USP36;CTSF;USP12;CASP3;USP15;USP10
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2348209458125386,-0.9607782301187613,0.5201238390092879,0.8794133644821407,1.0,12/100,7.21%,MYO10;CYTH3;ARAP2;HIP1;CERT1;ARAP3;HIP1R;DAB2IP;SNX3;CLVS1;KCNH1;AKT1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3621926678882307,-0.9592600862307539,0.5102040816326531,0.8785949231232716,1.0,3/15,6.29%,PIK3R1;PIK3R6;PIK3R3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.30430012360815695,-0.958796330703424,0.5246305418719212,0.8747381479342216,1.0,9/30,16.84%,CST3;GAS6;SNCA;SERPINB9;PTTG1;SPOCK1;RPS6KA1;CD27;UBE2O
prerank,endopeptidase activity (GO:0004175),0.24108593485106758,0.9585289479983341,0.5561160151324086,0.8367778589337356,1.0,39/257,14.28%,DPP4;USP18;ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;THSD4;CASP4;CPNE1;MMP14;CORIN;CTSH;USP24;USP9X;ESPL1;PSMB10;ACR;PLAU;PSMA3;USP8;USP47;CTSW;PSMA5;PMPCB;NLN;ADAM19;PAPLN;CELA1;PLAT;USP40;SENP1;ADAMTS7;KDM8;USP35;USP34;USP36
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3442620544693448,0.9584392337163344,0.5116696588868941,0.8336812538772582,1.0,5/28,11.18%,TRAF5;EDA;STAT1;CASP8AP2;TRAP1
prerank,G protein-coupled receptor binding (GO:0001664),0.25892025723720546,0.9573173424351743,0.5385694249649369,0.833025197424707,1.0,19/132,15.18%,WNT4;WNT6;GRK3;WNT10B;WNT3A;WNT2B;WNT5B;ARHGEF11;WNT5A;ADM;INSL3;ARHGEF12;HOMER3;DVL3;ARRB1;RNF43;CCL25;CCRL2;RYK
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.21110058903959467,-0.9550133999834085,0.6164383561643836,0.8798845575926658,1.0,71/248,22.39%,DNM3;GNAO1;RAB27A;RIT2;RERG;VWA8;ABCA3;GNAS;KIF1C;EEF1A1;NKIRAS1;MYL6;RAB6B;GTPBP1;RAB27B;RAB38;EEF2;RAB3C;ARL1;RHOB;ARHGDIB;RAB35;GFM1;RRAGB;ATAD1;ARL8A;MFN2;GCH1;RHOG;KIF26A;MFN1;HSP90AA1;GSPT2;ABCD2;KIF15;HRAS;RAC1;KRAS;RAB5C;GNA12;RHOH;GPN3;KIF5A;GNAQ;TOR1B;GNA14;IRGM;HBS1L;MYO18A;RAP1A;DNAJC27;RRAGC;RABL3;GNAL;GNA13;RHOBTB1;GPR88;TPPP;RAB1B;RAC3;SAR1B;IFT22;ATL2;BMS1;RND2;RAB32;GNG3;ARL2;GSPT1;RAB18;CHD1L
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.36438578666906307,-0.9518086072798226,0.5171673819742489,0.8833665083865595,1.0,3/14,14.45%,CAPN1;CAPN10;CAPNS1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.40166172438600556,-0.9506137077208596,0.5183585313174947,0.8815926773576115,1.0,4/10,6.26%,DPP10;DPP6;FAP;PRCP
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3427282432687537,-0.949247287696066,0.5077262693156733,0.8801597171136334,1.0,5/18,16.09%,GAS6;SNCA;SERPINB9;RPS6KA1;CD27
prerank,phosphatidylglycerol binding (GO:1901611),-0.37306786005945114,-0.9491286106082707,0.5286624203821656,0.8755836075422708,1.0,2/13,3.78%,PITPNC1;PITPNA
prerank,ephrin receptor binding (GO:0046875),0.35041600975312026,0.9489225734488156,0.5210237659963437,0.8493682612526648,1.0,4/21,12.77%,EFNB2;PTPN1;EFNA1;EFNB1
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.23614505907690123,-0.9477065107309537,0.5884244372990354,0.8743779282053145,1.0,25/85,30.27%,NDST3;MGLL;ABHD2;GDPD1;CA2;LIPE;BCHE;AOAH;GDE1;ABHD6;PLAAT3;LPL;PNPLA6;PNPLA3;PLA2G7;PLA2G4F;PAFAH1B2;FAAH;PTRH2;ABHD15;PLAAT1;LIPC;PLA2G4B;PGLS;PGAP1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.33346489022868864,-0.947003047224268,0.5386363636363637,0.8667391450326367,1.0,8/21,19.65%,CDK14;CDK6;CDK15;CDK19;CDKL2;CDK2;CDK4;CCNK
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.33346489022868864,-0.947003047224268,0.5386363636363637,0.8667391450326367,1.0,8/21,19.65%,CDK14;CDK6;CDK15;CDK19;CDKL2;CDK2;CDK4;CCNK
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3751540246615189,-0.9468157935774855,0.5344827586206896,0.8625381927175291,1.0,3/13,12.62%,PIP5K1B;PIK3C2B;PIK3CD
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.3983931086841558,-0.9444182023241361,0.5269978401727862,0.8640668041747385,1.0,7/10,41.56%,NCF2;CYBB;NOX4;NCF1;NOX3;NCF4;DUOX1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.40964468398164894,0.9435977565951978,0.5397727272727273,0.8585057461043368,1.0,4/12,10.02%,CDK8;CDK7;CDK12;BRD4
prerank,deoxyribonuclease activity (GO:0004536),-0.3614070990632526,-0.9431311573858022,0.5138592750533049,0.8627115310840237,1.0,2/14,5.90%,RPS3;MRE11
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3594035351167011,-0.9422640452834435,0.5570175438596491,0.8603787132684025,1.0,9/14,41.56%,NCF2;CYBB;KMO;NOX4;CYB5R4;NCF1;NOX3;NCF4;DUOX1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.35209305584125855,-0.9420730259222784,0.5484581497797357,0.8563331520497037,1.0,4/16,11.28%,MACROD2;RPS3;CD38;SMUG1
prerank,GTPase activity (GO:0003924),-0.21251937604064078,-0.9412705647743171,0.6255144032921811,0.853834720577809,1.0,57/192,22.27%,DNM3;GNAO1;RAB27A;RIT2;RERG;GNAS;EEF1A1;NKIRAS1;RAB6B;GTPBP1;RAB27B;RAB38;EEF2;RAB3C;ARL1;RHOB;ARHGDIB;RAB35;GFM1;RRAGB;ARL8A;MFN2;GCH1;RHOG;MFN1;GSPT2;HRAS;RAC1;KRAS;RAB5C;GNA12;RHOH;GPN3;GNAQ;GNA14;IRGM;HBS1L;RAP1A;DNAJC27;RRAGC;RABL3;GNAL;GNA13;RHOBTB1;TPPP;RAB1B;RAC3;SAR1B;IFT22;ATL2;BMS1;RND2;RAB32;GNG3;ARL2;GSPT1;RAB18
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4013958908691793,-0.9400737569478146,0.5244897959183673,0.8522805939304705,1.0,5/10,21.79%,SLC24A2;SLC8A1;SLC3A2;SLC8B1;SLC24A5
prerank,nuclear receptor coactivator activity (GO:0030374),0.29724990002158796,0.9399824964980759,0.5530546623794212,0.8634423572764391,1.0,16/52,18.40%,ZMIZ1;NCOA3;NCOA6;TACC1;SFR1;SS18;MED12;BRD8;NCOA2;CARM1;RBM14;CNOT9;CCAR1;TMF1;PPARGC1B;KDM1A
prerank,lipoprotein particle receptor binding (GO:0070325),0.34094459487516904,0.9392594390955217,0.5651408450704225,0.8618456400969422,1.0,4/27,6.66%,APOA2;HSPG2;APBB1;CRP
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3336873620530513,0.9390689692120642,0.5274336283185841,0.858855716012796,1.0,9/28,18.81%,PRKAA2;MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAPKAPK3;MAP2K4
prerank,neuropeptide hormone activity (GO:0005184),0.35866834052799096,0.9361805969523487,0.5483870967741935,0.8623679398348125,1.0,2/22,5.28%,GHRH;UCN
prerank,magnesium ion binding (GO:0000287),0.2552865523212371,0.9357657920468031,0.5930735930735931,0.859911617489403,1.0,32/135,19.45%,EYA2;OXSR1;TSSK3;DCTPP1;CLYBL;WRN;IDH1;STK3;SIK3;PDXK;LRRK2;GEM;HACL1;IRAK3;ADPRS;OPA1;SRPK1;IDH2;CIB2;NUAK2;FIGNL1;STK4;ERN2;YDJC;EPHX2;RAN;ABL2;DHX36;PGM1;TDP2;SRR;MVK
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.2914939405917926,-0.9347747565470956,0.5790754257907542,0.8609304548600264,1.0,11/33,18.10%,RNF144B;RNF144A;RPS3;DCUN1D2;UBE3D;DCUN1D5;DCUN1D1;RNF125;PARK7;FOXL2;TOLLIP
prerank,WW domain binding (GO:0050699),0.3311153189331247,0.9337066959026825,0.5318021201413428,0.861331572915886,1.0,6/26,12.55%,TCEAL7;PMEPA1;LITAF;SCNN1A;TCEAL3;TCEAL6
prerank,GTP binding (GO:0005525),0.24422062763847543,0.9336100593185037,0.5894039735099338,0.858221397118051,1.0,45/172,19.74%,GBP6;GBP2;RRAS2;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;RRAD;RHOQ;LRRK2;ARF3;RAP2C;GEM;RABL6;GBP7;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;TUBB2B;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;ARF1;RAN;RAP2B;LSG1;RHOT1;RANBP17;ARL6;DIRAS1;RHOT2;ARFIP2;NRAS
prerank,transcription corepressor binding (GO:0001222),0.3355700198368029,0.9334563663477063,0.5630397236614854,0.8553216808042778,1.0,2/27,3.79%,RORA;SUZ12
prerank,exopeptidase activity (GO:0008238),0.2922893821035038,0.9309207416070494,0.5930599369085173,0.8579304717216405,1.0,12/50,14.11%,DPP4;DPEP2;ANPEP;DPP8;NPEPPS;CTSH;ERAP1;BLMH;DPP7;RNPEP;LNPEP;KDM8
prerank,clathrin adaptor activity (GO:0035615),-0.3452352201479032,-0.9269105889985194,0.5627906976744186,0.8756392693669773,1.0,7/15,27.44%,HIP1;HIP1R;LDLRAP1;AP2B1;AP2A2;AP2A1;AP2M1
prerank,gated channel activity (GO:0022836),-0.3611543089062725,-0.9268346103343256,0.5796178343949044,0.8712851151029916,1.0,1/14,0.51%,PIEZO2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.32451048409223016,-0.9252785281634176,0.5768321513002365,0.8707800386263783,1.0,9/19,31.35%,HELQ;RAD51;RFC4;POLQ;WRNIP1;RFC5;RFC2;CHTF18;PIF1
prerank,GTPase binding (GO:0051020),0.23996139832025298,0.9231984471746811,0.6316472114137484,0.8724709775975082,1.0,41/194,16.55%,RAPGEF4;AKAP13;RNF152;AFDN;SPTBN1;RADIL;FGD4;AMBRA1;PARD6A;MYCBP2;UNC13B;RANBP2;PLCE1;OPTN;RASA1;EXOC2;RALBP1;NGFR;GOLGA5;CHM;STRN3;MICALL1;LRRK2;IQGAP2;DOCK7;TRIOBP;CDC42EP4;DNM1L;RAB34;DVL3;RAP1GAP;IFT20;WASF1;TBC1D7;MYO1C;ABCA1;GOLGA4;IQGAP1;NDRG1;MYO5A;NOX1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.24109976445564293,-0.9225951491940846,0.6303030303030303,0.8728963289689204,1.0,17/72,15.71%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;SDCBP;SYT7;STXBP6;LDLRAP1;RAB35;SNAP91;MARK1;KCNQ1;AMER2;SNX18;KRIT1;TWF1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.35425990243613203,0.9209878401187305,0.5555555555555556,0.874162885950685,1.0,3/20,8.89%,CMPK2;CASK;DLG1
prerank,calcium channel activity (GO:0005262),-0.23381294095170535,-0.9192864060985734,0.6554878048780488,0.8766679521843783,1.0,9/84,4.60%,CACNA1E;CACNB2;TRPC3;SLC24A2;RYR2;CACNB4;TRPC5;TRPC4;OPRM1
prerank,hexosyltransferase activity (GO:0016758),-0.2273570992756298,-0.9186462402085679,0.6479750778816199,0.8738709228901758,1.0,20/101,15.97%,TMTC2;CSGALNACT1;FUT9;HEXB;EXT1;POMGNT1;DPY19L1;LFNG;ALG5;MFNG;B3GNT2;B4GALT4;PIGM;MGAT4A;GCNT1;CHSY3;B3GNT9;TMTC3;B3GALNT2;POMGNT2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.30494459408925145,0.9179352274185719,0.586490939044481,0.8780252344194333,1.0,13/38,20.00%,PLA2G4A;SNX12;PLEKHA4;DENND1A;SNX27;WDR45B;ATG2A;SH3PXD2B;WIPI2;SNX21;PLEKHF1;RUBCNL;SESTD1
prerank,galactosyltransferase activity (GO:0008378),0.40889591907344425,0.9169648587691043,0.5804597701149425,0.8769106007040728,1.0,2/11,7.26%,A4GALT;B4GALT1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.41234393757109866,0.9169538354651596,0.5714285714285714,0.8736560762949507,1.0,4/10,15.61%,KDM7A;KDM2A;KDM8;KDM2B
prerank,ubiquitin protein ligase binding (GO:0031625),-0.199529025941371,-0.9158746059811211,0.7352941176470589,0.8761024814073453,1.0,67/254,22.01%,HSPA8;FOXO1;MID1;PRR5L;SMAD7;RPL5;ACTG1;RPL11;PRKAR1A;GABARAP;HSP90AB1;ATP6V0C;HERC2;SLF1;BAG1;MFHAS1;TNFRSF1B;HDAC6;GABARAPL1;UBB;PINK1;RFFL;ELOB;HSPBP1;SPOP;BAG6;CALR;MFN2;USP13;CD40;TNK2;ANKRA2;RPL23;NLK;GPI;PRKAR2B;TPI1;EGFR;HSP90AA1;UBOX5;WASHC1;KDM4A;FZD4;UBA52;CAMLG;TUBA1B;CDKN1A;HSPA5;GPR37;YOD1;BRCA1;LTBR;UBE2D1;CKB;TRIM37;PACRG;TRIM28;SMAD5;PATZ1;WRAP53;UBE2J1;FZD5;USP2;BAG4;NKD2;TRAF1;ATXN3
prerank,anion:anion antiporter activity (GO:0015301),-0.3321425320223512,-0.9150384435838533,0.5898617511520737,0.8737417167565326,1.0,2/17,1.62%,SLC26A7;SLC26A2
prerank,hormone activity (GO:0005179),0.28648649013070443,0.9142815089134987,0.5875,0.8764384969385208,1.0,7/54,16.13%,GHRH;PTHLH;UCN;NPPC;AGRP;CCL25;INHA
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.28709454342690144,0.9141025203114701,0.5892857142857143,0.8736090321182778,1.0,11/55,13.14%,MCU;ITPR1;ANXA2;SLC24A3;ATP2B4;TMEM165;PKD1L3;PANX1;TRPC1;GRIN3B;ATP2B1
prerank,double-stranded RNA binding (GO:0003725),0.2728535079108619,0.9136442103789505,0.617693522906793,0.8713527890375709,1.0,14/70,14.41%,SIDT1;EIF2AK2;DDX60;VIM;RC3H1;MTDH;ZBP1;OASL;OAS2;ADAR;ILF3;SUPV3L1;TARBP2;IFIH1
prerank,NADPH binding (GO:0070402),-0.3619806443686463,-0.9131885786313421,0.56,0.8734411524026228,1.0,4/13,25.66%,KCNAB1;MTRR;NDOR1;CRYZ
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3720562697908274,-0.9127066937080552,0.5602536997885835,0.8702593839356465,1.0,6/11,31.97%,SLC2A9;SLC5A11;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,ankyrin binding (GO:0030506),-0.32088694763427433,-0.9115588641009403,0.5881104033970276,0.8687961299781302,1.0,6/19,14.81%,CDH1;SLC8A1;NRCAM;SPTB;CACNA1D;PTPRC
prerank,signal sequence binding (GO:0005048),0.31342920323538087,0.9112699120133345,0.5825082508250825,0.873625041139307,1.0,5/35,7.24%,TNPO1;KDELR3;KPNA6;KPNA7;KPNA4
prerank,anion transmembrane transporter activity (GO:0008509),-0.36412572350896927,-0.9091239021275351,0.5752808988764045,0.8703173025702028,1.0,4/12,16.43%,ABCG2;SLC22A6;SLC39A8;ABCC5
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.39200263760566745,0.9081686904775035,0.5678776290630975,0.877488644662233,1.0,1/12,3.49%,AOX1
prerank,proton transmembrane transporter activity (GO:0015078),-0.26879972427298243,-0.9063019878523706,0.6370967741935484,0.8729849849069145,1.0,15/39,26.40%,CLCN3;ATP6V1B2;COX4I1;UQCRH;UQCR11;COX8A;NDUFA4;COX6A1;CLCN5;ATP6V1F;NDUFA4L2;CYB5A;UQCR10;UQCRQ;COX4I2
prerank,3'-5' DNA helicase activity (GO:0043138),0.36641798319989133,0.9049627232666673,0.5893186003683242,0.8814441060597435,1.0,5/16,13.29%,WRN;ASCC3;FBH1;FANCM;MCM6
prerank,protein tyrosine kinase binding (GO:1990782),-0.23557982087128415,-0.9022024268804688,0.6750700280112045,0.8786955466862875,1.0,14/71,14.92%,DOCK4;NRG3;GRB14;GRM5;BMPR2;GAS6;CEACAM1;DUSP22;RACK1;CBL;ACVR1;HSP90AA1;TJP2;SHC4
prerank,carboxy-lyase activity (GO:0016831),0.33618361075861874,0.9019126922893062,0.5676156583629893,0.8852110633263358,1.0,5/23,17.33%,AZIN2;BCKDHA;UMPS;FAHD1;PCK2
prerank,fibroblast growth factor binding (GO:0017134),0.33972496957351234,0.9015719485601403,0.5918727915194346,0.8827620686773259,1.0,3/21,5.56%,FGFR1;KL;GLG1
prerank,voltage-gated anion channel activity (GO:0008308),-0.3442462103487899,-0.9009643042106251,0.6124721603563474,0.87729806107835,1.0,5/15,16.91%,ANO1;CLCN3;CLCN1;VDAC1;CLCN5
prerank,1-phosphatidylinositol binding (GO:0005545),-0.34096905839117553,-0.9002075781541911,0.6008771929824561,0.87495944016257,1.0,4/15,15.39%,EPB41;SCARB1;SNAP91;WDFY1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3434937077330869,-0.9000636939498264,0.6082474226804123,0.8711503734456145,1.0,5/15,12.62%,PIK3C2B;PIK3R3;ATM;PI4K2A;PIK3CD
prerank,gamma-tubulin binding (GO:0043015),-0.31552405115598947,-0.8988792264420663,0.5873015873015873,0.8697029209383014,1.0,8/21,24.37%,PAK1;DIXDC1;ARHGEF7;BRCA2;RAB11FIP5;CDK5RAP2;RACGAP1;TUBGCP3
prerank,MAP kinase activity (GO:0004707),0.37029318234633013,0.8977748239902226,0.6055555555555555,0.8879808598985433,1.0,4/14,13.33%,MAPK4;MAPK6;MAPK14;MAPK9
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3162144187106347,0.8974705693024274,0.593698175787728,0.885424709505316,1.0,3/29,3.50%,SLC13A3;SLC19A1;SLC26A9
prerank,receptor antagonist activity (GO:0048019),0.35841635275723116,0.8971470627578052,0.5952380952380952,0.8828762212775056,1.0,4/17,17.49%,WFIKKN1;DKK3;LRPAP1;IL18BP
prerank,receptor tyrosine kinase binding (GO:0030971),0.27965724130301295,0.8969973613631897,0.6016129032258064,0.8800110811525651,1.0,12/56,14.53%,CBLB;GAB2;FRS2;PTPN14;ANGPT1;LRP4;PTPN2;SH2B3;MAP3K7;PTPN1;SHC2;NCK1
prerank,small GTPase binding (GO:0031267),0.23711669318512163,0.8955661098215915,0.6861702127659575,0.879900106881526,1.0,37/169,16.55%,RAPGEF4;AKAP13;RNF152;AFDN;FGD4;PARD6A;MYCBP2;UNC13B;RANBP2;PLCE1;OPTN;EXOC2;RALBP1;NGFR;GOLGA5;CHM;STRN3;MICALL1;LRRK2;IQGAP2;DOCK7;TRIOBP;CDC42EP4;DNM1L;RAB34;DVL3;RAP1GAP;IFT20;WASF1;TBC1D7;MYO1C;ABCA1;GOLGA4;IQGAP1;NDRG1;MYO5A;NOX1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.23574506190057898,-0.894305768701289,0.685459940652819,0.8759988957654182,1.0,13/70,15.97%,CSGALNACT1;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;MGAT4A;GCNT1;CHSY3;B3GNT9;B3GALNT2;POMGNT2
prerank,neuropeptide receptor binding (GO:0071855),0.37583581767219254,0.8914461438497779,0.6135922330097088,0.8856623817857687,1.0,1/14,2.01%,GHRH
prerank,triglyceride lipase activity (GO:0004806),-0.3105840660351394,-0.8909737564711243,0.6269315673289183,0.8797552729109236,1.0,5/20,28.38%,LIPE;LPL;PNPLA3;LIPH;LIPC
prerank,protein kinase activator activity (GO:0030295),-0.24218927208890365,-0.8903309855103446,0.6764705882352942,0.8769608661625639,1.0,13/60,15.47%,GRM5;RPLP1;CALM1;GAS6;CALM2;CALM3;STK11;FGF13;ALS2;GPRC5A;RGCC;CDKN1A;IRGM
prerank,aspartic-type peptidase activity (GO:0070001),-0.3782322261837993,-0.8878402764807483,0.6107784431137725,0.8784669581046934,1.0,1/10,6.54%,CTSD
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3925243522410946,0.884923806152949,0.6269230769230769,0.8963753046478649,1.0,3/11,11.36%,NAA16;NAA30;NAA15
prerank,RNA polymerase binding (GO:0070063),-0.32560322742919645,-0.8846051674819836,0.6177685950413223,0.8816220566956228,1.0,6/18,17.82%,TCERG1L;STOM;YTHDC2;ANP32B;BRCA1;PPIB
prerank,alpha-tubulin binding (GO:0043014),-0.282651878654067,-0.883544315332814,0.647887323943662,0.8797020452471045,1.0,8/31,13.20%,TTLL7;DIP2B;SNCA;EFHC2;HDAC6;ARL8A;TRIM36;WASHC1
prerank,androgen receptor binding (GO:0050681),-0.29033905713308433,-0.8830451033130766,0.6013667425968109,0.8767309179416728,1.0,6/25,14.75%,PRKCB;PKN1;TRIM68;CALR;KDM4C;PARK7
prerank,transcription coregulator binding (GO:0001221),0.2842250206607433,0.8825927275103189,0.6587677725118484,0.8982871567937379,1.0,4/50,4.00%,RORA;SMAD3;SUZ12;TERT
prerank,NADP binding (GO:0050661),0.3060231250028912,0.8818803085231638,0.6252189141856392,0.8966187835044319,1.0,6/32,7.82%,HSD17B1;GMDS;PGD;NOS2;DPYD;NNT
prerank,phosphatase activity (GO:0016791),0.2600253006991318,0.8761919501303033,0.6697819314641744,0.9054644114415553,1.0,12/73,12.11%,ATP1A2;PLPP3;DUSP10;DUSP28;PTPN22;DUSP16;MDP1;PLPPR3;NT5C;NOCT;PPP1CB;DUSP5
prerank,damaged DNA binding (GO:0003684),0.2794192964685218,0.8755886920731153,0.6419965576592083,0.9035149747817824,1.0,10/44,15.41%,CRY2;CREBBP;NTHL1;RPA3;XRCC1;DCLRE1A;RBBP8;OGG1;ERCC5;ERCC1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.25563710714464877,-0.873724768815822,0.7063492063492064,0.8926551825867071,1.0,8/42,12.61%,PLCG2;BCAR3;PIK3R1;SHE;PIK3R3;LDLRAP1;VAV1;SYK
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.20939615733135977,0.873354215399742,0.8174418604651162,0.905167483879812,1.0,84/431,17.71%,ATP1A2;GBP6;PRKAG2;ENPP1;OXSR1;GBP2;KSR1;TSSK3;RRAS2;BMPR1A;MYO1B;RAB10;DAPK1;RAB22A;ARL3;RRM1;TOP1;LATS2;TGFBR1;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;MAP4K1;WNK4;RRAD;STK3;RHOQ;SIK3;PDXK;LRRK2;ARF3;TLK2;RAP2C;PFKM;AKT3;GEM;HACL1;RABL6;GBP7;OAS2;TUBA1C;IRAK3;TUBE1;RHOC;CLPX;ABCD3;TUBB6;DAPK2;SRPK1;MCM6;PIP4K2B;RHOU;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ARL4A;ABCA1;STK4;ERN2;TUBB2B;HSPA9;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;P2RX4;MKNK2;ARF1;RAN;RAP2B;LSG1;CHD8;RHOT1;TAP2;DMPK
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.2517214222502465,-0.8725894301623253,0.6986301369863014,0.8909607237728497,1.0,13/51,17.03%,SLCO1C1;SLCO2A1;SLC7A5;SLC16A10;CLCN3;SLC5A5;SLC5A6;SLC22A6;SLC25A30;MFSD2A;SLC35E3;SLCO4A1;SLC20A2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3553262942393537,0.8616155828813562,0.6342342342342342,0.9266071364803175,1.0,3/14,9.52%,MTHFD1;ALDH4A1;PYCR3
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.2772854272322689,-0.8608467789446943,0.7107061503416856,0.9118813898163461,1.0,4/27,6.71%,SLC12A2;SLC9B2;CNNM4;ATP2A3
prerank,myosin binding (GO:0017022),0.26717709199506046,0.8595707936870455,0.689935064935065,0.9276145143596688,1.0,5/55,3.85%,CALD1;KIRREL1;SPATA6;TRAK1;RAB10
prerank,histone deacetylase binding (GO:0042826),0.2486823605025654,0.858944967719537,0.7480798771121352,0.9257561281619547,1.0,24/88,18.62%,GLI3;ZMYND15;DACT1;MIER3;BCOR;MIER1;FOXP3;HDAC4;TOP2B;MEF2A;GMNN;CIR1;SMG5;HOXA10;BHLHE41;HIC1;RAD9A;HDAC2;KAT2B;PKN2;NIPBL;YWHAE;DHX36;CHD4
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.29448659434550994,-0.8576752868576186,0.7004608294930875,0.9141019721385095,1.0,9/21,24.48%,REV3L;POLA1;POLE;POLD1;POLB;POLE3;POLQ;POLK;CHRAC1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.38230219953054434,0.8563702095372988,0.6469428007889546,0.9277945725410616,1.0,1/11,0.88%,ITPR1
prerank,adenyl ribonucleotide binding (GO:0032559),0.21152750548121663,0.8562497143647294,0.840937114673243,0.9248793295388122,1.0,43/291,14.75%,MPPED2;ATP1A2;RAPGEF4;PRKAG2;ENPP1;OXSR1;KSR1;TSSK3;BMPR1A;SLC19A1;MYO1B;DAPK1;RRM1;TOP1;LATS2;TGFBR1;POPDC2;CNBD2;MAP4K1;WNK4;STK3;SIK3;PDXK;TLK2;PFKM;AKT3;HACL1;OAS2;IRAK3;CLPX;ABCD3;DAPK2;SRPK1;MCM6;PIP4K2B;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ABCA1
prerank,phosphatidic acid binding (GO:0070300),0.3304686019508393,0.8551646476371985,0.6585365853658537,0.92393820426945,1.0,7/19,20.00%,SMPD3;PACSIN2;MICALL1;OPA1;MAPKAP1;PITPNM1;SESTD1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3491995730388209,0.8549021265660265,0.6555555555555556,0.9212249697738475,1.0,1/15,0.80%,SLC1A3
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.34496782182940317,0.8540613623987984,0.6636363636363637,0.9199049835015817,1.0,1/16,0.90%,SLC13A3
prerank,phospholipase activity (GO:0004620),0.2538913833090197,0.8535925588489642,0.6933744221879815,0.9176737269210344,1.0,7/67,10.74%,SMPD3;PLA2G4A;PLCE1;PLCB3;PLA2G4C;PLA2G6;ENPP2
prerank,low-density lipoprotein particle binding (GO:0030169),-0.3193998161921744,-0.853255789097954,0.6885593220338984,0.9190989984867257,1.0,4/16,7.10%,THBS1;SORL1;STAB1;SCARB1
prerank,mRNA binding (GO:0003729),0.2148386444741255,0.8522165272971466,0.8236024844720496,0.9173887417069049,1.0,59/249,20.84%,CELF2;RBMS1;RBMS3;SAMD4A;SHMT1;PTBP3;RBFOX2;PCF11;RC3H1;RBMS2;IGF2BP1;PABPC5;TPR;SECISBP2L;NANOS2;CPEB1;SRRM2;NOVA1;RNF20;SNIP1;HNRNPC;NYNRIN;NOCT;FUBP1;ACO1;TDRD7;IGF2BP2;SRSF4;EIF4ENIF1;DDX6;SF3B6;PTBP2;RBM5;THOC5;ZC3H12B;GEMIN5;RBM15;RBM14;SRSF5;CSTF3;HNRNPR;CPEB3;SSB;HNRNPA2B1;PUM2;FXR2;SHFL;SLBP;PCBP2;DHX36;GRSF1;NANOS1;DDX5;KHDRBS1;IREB2;KHSRP;RBM25;ELAVL1;PARN
prerank,phosphatidylinositol binding (GO:0035091),-0.21323015610179322,-0.8498755292592187,0.8100890207715133,0.9218302104729538,1.0,18/91,15.43%,EPB41;MCF2L;HIP1;PITPNC1;PITPNA;HIP1R;MPPE1;CCDC88A;SCARB1;SNAP91;PIGU;PIGK;FES;GAP43;SNX8;PASK;WDFY1;MAPT
prerank,acetylcholine receptor activity (GO:0015464),-0.299978424447718,-0.8476676829400149,0.7108695652173913,0.9222040191291903,1.0,5/22,20.27%,CHRM3;CHRM2;CHRNA4;CHRFAM7A;CHRNA7
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3080114264653784,0.8462795231758351,0.6718480138169257,0.9263158549491233,1.0,4/22,12.11%,DUSP10;MTMR3;DUSP16;DUSP5
prerank,DNA polymerase activity (GO:0034061),0.31571322623931364,0.843709709800687,0.6654991243432574,0.9282978870144508,1.0,4/22,8.90%,POLH;TERT;POLG;REV1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.320760828328745,0.8407356000465022,0.6547169811320754,0.9310288281150734,1.0,2/18,5.07%,HSD17B1;RDH5
prerank,metalloexopeptidase activity (GO:0008235),0.266574288631121,0.8394718851569629,0.7311475409836066,0.9303630964806968,1.0,12/51,14.02%,CPQ;ANPEP;AEBP1;MMP14;PEPD;NPEPPS;CPB2;ERAP1;RNPEP;CPXM2;AGBL2;LNPEP
prerank,mannose binding (GO:0005537),0.36367518972579277,0.8391505672118157,0.6659707724425887,0.9278979592028668,1.0,3/12,13.88%,CLN5;ACR;LMAN1L
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2692496241237131,-0.838975296730357,0.7313084112149533,0.9357802956277342,1.0,10/29,22.24%,CIT;PRKAR1A;INKA2;SPRED2;PRKAR2B;PKIG;CDKN1A;PKIB;SPRED1;HEXIM2
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2866607093738844,-0.8345434269362685,0.7189695550351288,0.9406190235591418,1.0,5/21,18.69%,AKAP6;RYR2;KCNQ1;AKAP1;AKAP5
prerank,neuropeptide receptor activity (GO:0008188),-0.268386208759596,-0.832236051925283,0.7482678983833718,0.9408601225654292,1.0,8/29,25.91%,SORCS1;SORCS3;OPRM1;TACR3;GPR37;NMUR2;GRPR;KISS1R
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3595813112161792,-0.830956040170881,0.7014314928425358,0.939202588733351,1.0,2/10,7.38%,ADARB2;APOBEC1
prerank,calcium-release channel activity (GO:0015278),0.33042951552604355,0.8298608716374282,0.7034990791896869,0.9426271986731682,1.0,6/17,20.85%,ITPR1;TPCN1;PKD2;TRPA1;ITPR2;ITPR3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.33075275301044293,0.8284310054197673,0.6714031971580817,0.9423059315509781,1.0,6/16,21.36%,SLC5A7;SLC22A2;SLC22A4;SLC44A2;SLC7A8;SLC22A3
prerank,lipoprotein particle binding (GO:0071813),0.3190834264410278,0.8270762052870244,0.6985018726591761,0.9416934381016527,1.0,4/20,11.03%,COLEC12;APOA2;CRP;CDH13
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3367623285323664,-0.8263782553427023,0.7109704641350211,0.9436088797719124,1.0,6/12,17.19%,JMJD1C;KDM4D;KDM4C;KDM4A;PHF2;HR
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2809805895295955,-0.8250537152693119,0.7399103139013453,0.9420066510955464,1.0,5/26,10.48%,AGBL4;CPE;CPD;CPA6;ACE2
prerank,cysteine-type peptidase activity (GO:0008234),0.24609273304174306,0.824620301472216,0.7841079460269865,0.9432160323363636,1.0,19/73,18.30%,USP18;CASP4;CTSH;USP24;USP9X;ESPL1;USP8;USP47;CTSW;BLMH;USP40;USP35;USP34;USP36;CTSF;USP12;CASP3;USP15;USP10
prerank,single-stranded RNA binding (GO:0003727),-0.24357332467068193,-0.8238334607655976,0.7463768115942029,0.9401465753669375,1.0,6/43,8.16%,STRBP;PTBP1;ADARB2;ZFR2;CNBP;DDX11
prerank,peptidase activator activity (GO:0016504),-0.2884346346415232,-0.8236360496680302,0.7239819004524887,0.9364913103108883,1.0,6/22,17.43%,MAL;PSMD14;PINK1;CAV1;PSENEN;PSME1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3004702933314458,0.8223999962071301,0.7112299465240641,0.9443401446802052,1.0,1/26,0.48%,PTN
prerank,pseudouridine synthase activity (GO:0009982),-0.3176690111768383,-0.8205265824041909,0.7278350515463917,0.9386039472037713,1.0,7/13,28.33%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;RPUSD3;RPUSD1
prerank,CCR chemokine receptor binding (GO:0048020),0.2898900319181839,0.8126723791831388,0.7291311754684838,0.9593868887012027,1.0,5/28,15.02%,MSMP;CCL2;NES;CCL25;CCRL2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.307627251849168,0.8122107543058494,0.7312859884836852,0.9571828548264325,1.0,9/22,22.79%,RBMS3;CPEB1;ILF3;CPEB3;DHX36;KHSRP;ELAVL1;ZC3H12A;ZFP36L2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.33418844010473847,-0.8120051861053806,0.704312114989733,0.9504560592455794,1.0,2/12,11.18%,ENTPD1;SLC25A42
prerank,nucleosomal DNA binding (GO:0031492),0.30138272436269964,0.8112045709006603,0.6931216931216931,0.9558748794177236,1.0,8/21,18.62%,MBD2;HNRNPC;GATAD2B;ACTL6A;HDAC2;SMARCA4;SMARCC1;CHD4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2966200790167115,0.8111998472829296,0.737649063032368,0.9528077195027699,1.0,2/24,3.86%,CAMK1D;DAPK1
prerank,palmitoyltransferase activity (GO:0016409),-0.26317780517385564,-0.8089757604854939,0.7729357798165137,0.9518834473240404,1.0,13/28,33.48%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC5;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,death domain binding (GO:0070513),0.3533374008367562,0.8083269343625871,0.7032136105860114,0.9549504285897445,1.0,4/11,10.73%,BCL2;MCL1;BAX;BCL2L1
prerank,kinase activator activity (GO:0019209),-0.2538825453967789,-0.8080980284500511,0.7939110070257611,0.9495060859801588,1.0,6/30,13.86%,RPLP1;STK11;MALT1;FGF13;GPRC5A;RGCC
prerank,SH2 domain binding (GO:0042169),0.28030067675709747,0.8072254616849956,0.7367458866544789,0.9537065853648461,1.0,3/31,3.64%,DLC1;DAG1;AFAP1
prerank,solute:proton symporter activity (GO:0015295),-0.2975025940582985,-0.8063677343650522,0.7460674157303371,0.9484134115895121,1.0,12/16,44.77%,SLC15A2;SLC2A9;SLC36A1;SLC39A8;SLC36A2;SLC2A10;SLC15A1;MFSD3;SLC15A4;SLC11A2;SLC25A3;SLC2A13
prerank,syntaxin binding (GO:0019905),-0.22049347270844272,-0.8060080515324416,0.837465564738292,0.9449987286600382,1.0,22/61,26.68%,SYT1;SYNPR;NSF;SNAP25;STXBP5L;STXBP1;STX16;CPLX1;SNPH;NAPA;SYT9;SYT2;CACNA1A;SYPL1;SYT6;VPS18;SYT10;SYT5;VAMP1;STX7;SNAP29;SYT17
prerank,Toll-like receptor binding (GO:0035325),-0.3332364122364462,-0.8040597834713161,0.7278481012658228,0.9445145334678043,1.0,7/11,33.67%,DAB2IP;TOLLIP;MYD88;TLR6;TLR1;S100A9;TIRAP
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.28030988140898616,0.8026650249494717,0.7328646748681898,0.9588339978180002,1.0,7/31,15.01%,UBE2U;UBE2Z;UBE2C;UBE2E3;UBE2Q2;BIRC6;UBE2R2
prerank,disordered domain specific binding (GO:0097718),0.2918128090637184,0.8002735522599627,0.75177304964539,0.9597695278859465,1.0,3/23,8.31%,FN1;NCOA3;TEAD2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.26929399523649056,-0.7995263943792013,0.7721238938053098,0.9480292806271604,1.0,10/24,28.90%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC4;GOLGA7B
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2328056186797442,0.7973959034053453,0.8330893118594437,0.9617152304140337,1.0,30/83,24.12%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,P-type ion transporter activity (GO:0015662),-0.32378477994584753,-0.7965597119505448,0.7348314606741573,0.9489605956290003,1.0,6/12,27.63%,ATP2C1;ATP2A3;ATP2A2;ATP2B3;ATP2B2;ATP2C2
prerank,Notch binding (GO:0005112),0.29521647331964385,0.7961146190184613,0.7397504456327986,0.9609862978454333,1.0,3/22,5.80%,SNED1;AAK1;DTX1
prerank,kinase inhibitor activity (GO:0019210),-0.24583782759624886,-0.7960302596871585,0.8112745098039216,0.9458764259102335,1.0,9/33,15.23%,SNCA;SMCR8;NPM1;LRP6;SH3BP5L;MAPK8IP1;PRKRIP1;RHOH;CDKN1A
prerank,myosin V binding (GO:0031489),-0.3116090757475073,-0.7955329943525924,0.7398720682302772,0.9428385760689639,1.0,3/15,7.38%,RAB6B;RAB27B;RAB3C
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.31150542297453,-0.7946205470133566,0.7727272727272727,0.9404937228663945,1.0,7/13,51.26%,MIF;ECI1;IDI1;DCT;HSD3B2;EHHADH;IDI2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.24578524374804772,0.7925784601235397,0.8109854604200323,0.964103822825526,1.0,18/54,20.86%,MIER3;MIER1;HDAC4;ACY3;ASPA;NTAN1;HINT3;NAAA;ACR;SIRT4;AMDHD2;HDAC2;PDF;AGA;NIT1;PIGL;SIRT2;NADSYN1
prerank,hexosaminidase activity (GO:0015929),0.3402045932128549,0.792376215035121,0.7213114754098361,0.961452383503483,1.0,1/12,2.28%,CEMIP2
prerank,histone demethylase activity (GO:0032452),0.28364520959813233,0.7873355728535419,0.7464788732394366,0.9669161036078122,1.0,9/27,20.38%,KDM7A;KDM3B;JARID2;KDM5B;KDM2A;KDM8;KDM2B;KDM1A;JMJD6
prerank,N-methyltransferase activity (GO:0008170),0.29988614263898067,0.7864104412305293,0.7376146788990826,0.9654368201140587,1.0,7/20,23.12%,HNMT;ZCCHC4;FDXACB1;PEMT;METTL15;METTL5;PRMT1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.23908116891085904,-0.7838600053958642,0.7921052631578948,0.9537871455634982,1.0,12/38,23.13%,SHANK3;PIK3R1;SHANK2;GRIP1;LDLRAP1;MAPK8IP3;MMS19;SHANK1;DEDD2;CARD10;NUP62;IRS1
prerank,GDP binding (GO:0019003),0.23651079451892648,0.7832927575257087,0.8245341614906833,0.9677608726524005,1.0,19/63,23.16%,RRAS2;RAB10;RAB22A;ARL3;RAP2C;GEM;MIEF1;RAB5A;RIT1;TRIM23;RAN;RAP2B;GNAI3;DIRAS1;NRAS;RAB14;RRAGD;RAP2A;RAB11B
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.28513986176593825,0.7793047624358732,0.7699115044247787,0.9713200505961579,1.0,4/27,6.37%,RNF217;RNF19A;SIAH2;PPARA
prerank,hyaluronic acid binding (GO:0005540),-0.3299962836256614,-0.77918024916377,0.7452631578947368,0.9569351754499142,1.0,2/10,4.97%,LAYN;CEMIP
prerank,Wnt-activated receptor activity (GO:0042813),0.31642092571278524,0.779168034415435,0.75,0.9685277136700854,1.0,2/15,4.47%,FZD2;ROR1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.28726621268646824,0.7787987750287373,0.761986301369863,0.9661104266119477,1.0,8/24,20.00%,PLA2G4A;OSBPL8;OSBPL5;PLEKHA8;PLEKHF1;ARFIP2;RUBCNL;SESTD1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3182971720383039,0.7769577530759958,0.7371323529411765,0.966068130427101,1.0,5/15,20.00%,PLA2G4A;SH3PXD2B;PLEKHF1;RUBCNL;SESTD1
prerank,SUMO binding (GO:0032183),0.32955602961412156,0.7769152493907742,0.7344632768361582,0.9631776331829961,1.0,4/13,15.00%,RNF111;CASP8AP2;CBX4;PML
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.23557392172605118,-0.774261541930281,0.8212435233160622,0.9605781124156568,1.0,10/34,22.27%,DIS3L2;EXOSC2;EXD2;ANGEL2;XRN2;CNOT2;ERI1;EXOSC4;CNOT8;TOE1
prerank,ADP binding (GO:0043531),-0.2581835667686637,-0.7734696361070862,0.8382687927107062,0.9578524562611751,1.0,6/25,15.94%,ME1;PGK1;ATP5F1A;GCLC;ATP5F1D;MYO18A
prerank,MHC protein binding (GO:0042287),-0.2757573039899497,-0.7727906303338136,0.7846481876332623,0.9549536429756754,1.0,4/20,14.24%,ATP5F1A;CD74;ATP5F1B;TUBB4B
prerank,neuropeptide binding (GO:0042923),-0.279787360202984,-0.7708142617271403,0.775377969762419,0.9541147869624766,1.0,2/18,4.64%,OPRM1;SORL1
prerank,muscle alpha-actinin binding (GO:0051371),0.3066795580269153,0.7706743084196065,0.7737881508078994,0.9700000027344753,1.0,7/15,26.77%,SYNPO2;PRICKLE4;PKD2;PDLIM2;PDLIM7;PDLIM1;PDLIM5
prerank,heme binding (GO:0020037),-0.20666454791166278,-0.7706188561969484,0.8960674157303371,0.9505282006484337,1.0,20/65,28.13%,NOS3;SDHC;GUCY1B1;NOS1;HMOX2;CYP2A6;PTGIS;CYBB;HEBP1;EIF2AK1;CYP2S1;SDHD;CYP46A1;CYB5A;NOX4;CYP2R1;HMOX1;ABCB6;STEAP4;CYP26B1
prerank,ferrous iron binding (GO:0008198),-0.2739474683023404,-0.7696453796763337,0.7853881278538812,0.9481069441611638,1.0,3/21,4.96%,FTH1;SNCA;FTL
prerank,chemoattractant activity (GO:0042056),0.2746949466465446,0.7692494738180433,0.7901234567901234,0.9693238411639702,1.0,2/26,3.32%,CXCL10;VEGFD
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.1928103950137697,0.7678912527953248,0.9564134495641345,0.9685342961956835,1.0,47/269,16.38%,SMAD3;STAT2;AMBRA1;TRAF5;PARP9;APBB1;IKBKE;BCL2;VCL;PTPN22;DTX1;CUL4A;FHIT;DTX3L;CCDC50;RNF20;NGFR;STAT1;GSK3B;TNFRSF14;SKI;SNX9;UBE2C;PSMA3;SLC22A18;SUMO1;SLF2;SMAD6;TRIOBP;DIO2;DNM1L;SPOPL;SMG5;CUL3;EGR2;ARRB1;JAK1;RTN4;TRIB1;PML;FAF2;MUL1;CXCR4;POU5F1;HSPA9;SMAD2;AXIN2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.27267293643722373,0.7676846149080051,0.8086522462562395,0.9659235510652553,1.0,11/29,19.09%,LCT;ABHD10;MGAM;ADPRS;CTBS;GANAB;GANC;NEU3;GBA2;PGGHG;IDUA
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.262708579025936,0.7663245031692741,0.7847896440129449,0.9650921145135279,1.0,9/34,17.02%,FAM20A;STK3;IGF2;PARP16;MAP2K1;MTCP1;IQGAP1;STK4;RICTOR
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.329818466448517,-0.7656366182743941,0.7543859649122807,0.9500538278734612,1.0,5/10,30.98%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,cation transmembrane transporter activity (GO:0008324),0.24227496006769514,0.757528743437228,0.8291873963515755,0.9755945207725195,1.0,7/48,12.14%,SLC7A2;SLC6A9;SLC38A6;PKD1L3;SLC41A1;SLC38A1;SLC38A9
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3238318302497629,0.7572967211023738,0.7661795407098121,0.9730247785132016,1.0,2/11,14.62%,FBXO11;CARM1
prerank,adenylyltransferase activity (GO:0070566),0.2839777429386866,0.753877317293835,0.7885615251299827,0.9748947443985367,1.0,9/21,24.46%,PAPOLG;OASL;OAS2;TENT2;PAPOLB;FLAD1;TENT4B;SELENOO;PAPOLA
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.2841354332354669,-0.7538599490694904,0.7923728813559322,0.9624938619181921,1.0,7/14,25.38%,MTMR6;MTMR12;MTMR7;MTMR2;MTMR1;SYNJ1;MTMR9
prerank,ATP binding (GO:0005524),0.18677721483137075,0.7506897868958137,0.9735516372795969,0.9765139369523568,1.0,38/266,14.75%,ATP1A2;PRKAG2;ENPP1;OXSR1;KSR1;TSSK3;BMPR1A;MYO1B;DAPK1;RRM1;TOP1;LATS2;TGFBR1;MAP4K1;WNK4;STK3;SIK3;PDXK;TLK2;PFKM;AKT3;HACL1;OAS2;IRAK3;CLPX;ABCD3;DAPK2;SRPK1;MCM6;PIP4K2B;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ABCA1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.28369801466910854,0.7489412705270195,0.7989228007181328,0.9760350819629446,1.0,3/22,6.66%,HSPG2;APBB1;CRP
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2736060071842561,-0.7481913855995801,0.8095238095238095,0.9664645897392865,1.0,7/16,25.38%,MTMR6;MTMR12;MTMR7;MTMR2;MTMR1;SYNJ1;MTMR9
prerank,5'-3' exonuclease activity (GO:0008409),-0.2860523112098532,-0.7448279739827218,0.8016032064128257,0.9669564774680851,1.0,9/14,32.50%,MRE11;XRN2;DCLRE1C;CPSF3;FAN1;EXO1;DCLRE1B;FEN1;TRIR
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.31259553475739854,0.7442705631805615,0.7648221343873518,0.9797265200410933,1.0,3/13,18.20%,AGPAT4;AGPAT3;ABHD5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.32998556273931356,0.7439435685272445,0.7670682730923695,0.9772382057987831,1.0,11/11,67.02%,DDAH2;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;DDAH1
prerank,CARD domain binding (GO:0050700),-0.28580035197151354,-0.742406859701782,0.7840172786177105,0.9663339113876411,1.0,5/14,20.03%,NOD1;IRGM;NOD2;CARD10;CASP1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.2791020627573372,-0.7398753104473721,0.8344086021505376,0.965602422820206,1.0,6/14,22.01%,MINDY3;USP13;MINDY2;YOD1;MINDY1;ATXN3
prerank,ATPase activator activity (GO:0001671),0.28023722920811606,0.7398136894368209,0.797153024911032,0.980009725295573,1.0,6/20,18.88%,DNAJA2;TOR1AIP1;DNAJC1;ATP1B2;DNAJB2;DNAJB6
prerank,DNA replication origin binding (GO:0003688),0.2695865137432802,0.7388372480311354,0.8162544169611308,0.9784272167450515,1.0,5/23,15.44%,ORC5;MCM4;MCM6;ORC3;ORC4
prerank,G protein-coupled receptor activity (GO:0004930),0.18712754276903026,0.7330844669583169,0.9747793190416141,0.9830712784342647,1.0,17/239,7.58%,LPAR1;ADGRD1;LGR4;FPR2;ADORA2A;GCGR;ADGRV1;F2RL3;GLP2R;MC2R;C5AR2;PDGFRB;QRFPR;RXFP2;BDKRB2;OPRD1;ADGRL1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3120521265946303,-0.7314652133513888,0.8055555555555556,0.9723913173990634,1.0,6/10,40.60%,NAA50;BRCA2;USP22;MSL3;KAT8;HAT1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.28526171936692707,-0.7279954645247735,0.8176229508196722,0.9728527252878042,1.0,6/13,18.89%,PLPPR1;PLPP5;PLPP1;PLPPR2;LPIN3;PLPPR5
prerank,serine-type peptidase activity (GO:0008236),0.2059484985208692,0.7274107444500596,0.9279279279279279,0.9874390182702276,1.0,9/96,12.98%,DPP4;PRSS57;CORIN;CTSH;ACR;PLAU;ENDOU;CELA1;PLAT
prerank,ribonuclease P activity (GO:0004526),-0.3001118979207406,-0.7257713185353662,0.8199152542372882,0.9715927420265158,1.0,2/11,12.68%,PRORP;RPP30
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3221410660682158,0.7249647090126036,0.8197674418604651,0.9876143492402965,1.0,4/11,20.15%,RAD50;HNRNPA2B1;CTC1;NABP2
prerank,ATPase regulator activity (GO:0060590),0.2389992619657338,0.7244309409359919,0.8610662358642972,0.9854086515000405,1.0,11/38,18.88%,SIL1;DNAJA2;TOR1AIP1;DNAJC1;FNIP1;ATP1B2;GRPEL1;DNAJB2;ATP5IF1;HSPH1;DNAJB6
prerank,aspartic-type endopeptidase activity (GO:0004190),0.3124921531701193,0.7220647024871457,0.7925636007827789,0.9854624232092809,1.0,12/12,68.77%,SPPL3;PSEN1;BACE2;SPPL2A;DDI2;BACE1;PGC;ASPRV1;SPPL2B;CTSE;NAPSA;HM13
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2640701125623541,0.7215892783706063,0.8479020979020979,0.9832212094337912,1.0,1/24,0.82%,CMPK2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24672578532987285,0.7209156956913567,0.8732876712328768,0.9812042595221939,1.0,7/34,15.01%,UBE2U;UBE2Z;UBE2C;UBE2E3;UBE2Q2;BIRC6;UBE2R2
prerank,MHC class I protein binding (GO:0042288),-0.2866455668967307,-0.7186381456962827,0.831275720164609,0.9761483368652977,1.0,3/13,14.24%,ATP5F1A;ATP5F1B;TUBB4B
prerank,BMP binding (GO:0036122),0.31311442516771587,0.7178812700487454,0.7988394584139265,0.982149755051837,1.0,1/11,2.59%,NBL1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.2975679611228652,-0.7165618330559063,0.8092243186582809,0.9748122783576778,1.0,3/11,12.13%,MAP3K5;MAP3K20;EGFR
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.21873466301998673,-0.7151397510153042,0.8953771289537713,0.9726238393396336,1.0,7/35,15.78%,H3-3A;NPM1;SMARCB1;HDAC1;RRN3;PARK7;KLF10
prerank,death receptor binding (GO:0005123),-0.26415161393819614,-0.7106347572211404,0.8547368421052631,0.9739425391156448,1.0,7/15,30.17%,DAB2IP;NGF;TMBIM1;NTF3;MYD88;FADD;PIDD1
prerank,chloride channel regulator activity (GO:0017081),0.28819791057411626,0.7101577458163052,0.8170974155069582,0.9883953570067194,1.0,3/14,14.09%,WNK4;STX8;WNK1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.28910513166601903,0.7100409490448202,0.8064516129032258,0.9856927004834594,1.0,2/15,11.23%,AGPAT4;AGPAT3
prerank,thioesterase binding (GO:0031996),0.3125056151690793,0.708149645921446,0.8204633204633205,0.9851799345053384,1.0,1/11,3.11%,TRAF5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.2764891027473238,0.7081298445734074,0.8397085610200364,0.9824115850689733,1.0,4/17,13.64%,DPYD;PTGR1;LBR;PECR
prerank,lipid phosphatase activity (GO:0042577),-0.2783539627361252,-0.7075835278669141,0.8571428571428571,0.9735087879651175,1.0,6/14,18.89%,PLPPR1;INPP5K;PLPP1;PLPPR2;SGPP1;PLPPR5
prerank,deubiquitinase activity (GO:0101005),0.20617077110993495,0.7074634748630994,0.9424778761061947,0.980394602320365,1.0,30/88,24.12%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,carboxypeptidase activity (GO:0004180),-0.22204129165215536,-0.70703117013927,0.8907766990291263,0.9704137320454035,1.0,10/35,22.12%,AGBL4;CPE;CPD;CPA6;ACE2;MINDY2;CPXM1;VASH1;MINDY1;CPZ
prerank,histone deacetylase activity (GO:0004407),0.26992092370992626,0.7063210364540727,0.8342440801457195,0.9789042206570313,1.0,3/19,6.29%,MIER3;MIER1;HDAC4
prerank,omega peptidase activity (GO:0008242),0.20294116574699606,0.7042254132696645,0.9464544138929089,0.9783520610448289,1.0,31/89,24.12%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;APEH;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3039548022598868,0.7033595348326077,0.8234200743494424,0.9765583152083193,1.0,12/12,69.63%,GEMIN5;CYFIP2;CYFIP1;LARP1;NCBP3;AGO2;EIF4E2;EIF4E3;NCBP2;NCBP1;EIF4E;DCPS
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.2879251240531256,-0.7003241073709545,0.8429752066115702,0.969932140341724,1.0,5/11,24.78%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,adenyl nucleotide binding (GO:0030554),-0.2879251240531256,-0.7003241073709545,0.8429752066115702,0.969932140341724,1.0,5/11,24.78%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2203235598564008,0.6951995759085482,0.9244663382594417,0.9824494997629749,1.0,5/49,6.86%,ZFAND6;IKBKE;OPTN;DZIP3;PARP10
prerank,DNA polymerase binding (GO:0070182),-0.24929471493312086,-0.6925232606640619,0.8950892857142857,0.9739648851943398,1.0,4/18,16.12%,HMGB1;HSP90AB1;HSP90AA1;RAD51
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2716979817467089,-0.6906925730883529,0.8666666666666667,0.9720192941810158,1.0,6/13,24.51%,ZGRF1;DICER1;GEN1;ENDOV;FAN1;EXO1
prerank,FMN binding (GO:0010181),0.3058210092780298,0.6869837699822227,0.8284600389863548,0.9881971041325281,1.0,3/11,13.81%,POR;NOS2;HAO1
prerank,serine-type endopeptidase activity (GO:0004252),0.1992774344754479,0.686021734777359,0.9502332814930016,0.9864710369335051,1.0,7/80,12.98%,DPP4;CORIN;CTSH;ACR;PLAU;CELA1;PLAT
prerank,ribonuclease activity (GO:0004540),0.21181246821419186,0.6859561950745965,0.9269102990033222,0.9837824888171712,1.0,16/56,23.79%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;SLFN14;ZC3H12B;ERN2;EXOSC10;RNASEH1;RNASE3;RNASEL;YBEY;ZC3H12A;KHNYN;RNASEH2A
prerank,ribosome binding (GO:0043022),0.2164477352103428,0.6832369191499703,0.9363784665579119,0.9836791046843907,1.0,11/46,16.03%,SRP68;SBDS;CPEB1;NAA16;NAA15;SLFN14;EFL1;GEMIN5;MRPS27;CPEB3;SRP19
prerank,Hsp70 protein binding (GO:0030544),-0.2152383975427857,-0.6808351677047746,0.9359605911330049,0.9773725022564481,1.0,16/31,42.21%,SNCA;RPS3;NOD2;GPR37;SACS;PACRG;DNAJA1;MVD;METTL21A;IQCG;CYP2E1;TSC1;DNAJC8;CYP1A1;FICD;HDAC8
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3087418563198754,0.6787759781888826,0.8290766208251473,0.9854028649454146,1.0,2/10,7.52%,DSE;GLCE
prerank,protein kinase regulator activity (GO:0019887),0.1930108862881003,0.6769251911010724,0.964963503649635,0.9844872302736316,1.0,5/95,5.19%,CXCL10;PRKAG2;PARVA;TAOK3;CCND3
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.28907934253894985,-0.676323776126137,0.865546218487395,0.9777750110336897,1.0,5/10,30.98%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.22277148947395972,-0.675364449903475,0.9307875894988067,0.9750022047887189,1.0,5/26,15.86%,CSGALNACT1;B3GNT2;CHSY3;B3GNT9;B3GALNT2
prerank,four-way junction DNA binding (GO:0000400),0.2670377634878586,0.6752830433511414,0.8584558823529411,0.9833178814666574,1.0,3/17,13.34%,WRN;FANCM;RAD51B
prerank,microtubule plus-end binding (GO:0051010),0.25937324423601865,0.6749985741395542,0.8915441176470589,0.9809272696313885,1.0,7/20,23.17%,CLASP1;CLIP4;FBXW11;TTBK2;MAPRE3;CLIP3;MAPRE2
prerank,ATP hydrolysis activity (GO:0140603),0.22284210951164407,0.67199577387878,0.9272419627749577,0.9810253877278519,1.0,2/41,1.89%,RNF213;ABCA4
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.29567500632702887,0.6689887706333757,0.8299445471349353,0.9810500378748613,1.0,4/12,21.06%,NOCT;PAN3;PARN;PAN2
prerank,tRNA binding (GO:0000049),0.22091153990364118,0.6681816845716773,0.93354943273906,0.9790917964787939,1.0,10/43,16.10%,TERT;SEPSECS;PUS1;CTU1;TRNAU1AP;TRMT10B;TRNT1;ALKBH1;MRPS27;SSB
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.27694338907812527,-0.6678213975329602,0.897489539748954,0.9777800975586594,1.0,5/11,39.59%,RDH11;DHRS13;RDH12;ALDH3A1;RDH13
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2495122523054315,0.6674962382725265,0.8864468864468864,0.9770877198156653,1.0,3/22,6.86%,IKBKE;OPTN;PARP10
prerank,O-methyltransferase activity (GO:0008171),-0.2852795247961259,-0.6660150471092765,0.867237687366167,0.9757020256253393,1.0,3/10,22.46%,ASMT;FTSJ3;COQ3
prerank,ubiquitin-specific protease binding (GO:1990381),-0.2392944599092585,-0.6632751869786695,0.9272349272349273,0.9744463141209684,1.0,4/19,14.75%,RAD23A;SART3;BAG6;PARK7
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.25460103829749714,0.656814865714799,0.8948339483394834,0.983483779293527,1.0,9/20,25.87%,USP9X;USP47;SENP3;SENP1;USP7;OTUD5;USP25;SENP2;DESI2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.29270962793699234,0.6561821347739222,0.8932806324110671,0.9814225538102552,1.0,5/10,31.06%,ECHDC3;HADHA;ECHS1;ECHDC2;HSD17B4
prerank,RNA cap binding (GO:0000339),0.26676968844073157,0.6559066439739861,0.8656716417910447,0.9790232556639002,1.0,5/16,25.93%,LSM1;GEMIN5;CYFIP2;CYFIP1;LARP1
prerank,hydro-lyase activity (GO:0016836),-0.19459590798640175,-0.6545692867563717,0.9536082474226805,0.9774873092267465,1.0,8/41,16.00%,CA4;CA2;PARK7;FAHD2A;ENO1;HACD3;APIP;CYP2S1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.26023607034565965,-0.6372227127793405,0.9069264069264069,0.9857832311187935,1.0,2/12,9.20%,H3-3A;HDAC1
prerank,ATPase binding (GO:0051117),0.1885009803126374,0.6356881520668882,0.9758064516129032,0.9918774676708465,1.0,17/71,18.97%,TMTC4;SLC26A9;PTPN3;SNTA1;TOR1AIP1;TRPC1;ATP1B2;TCIRG1;ABCA1;CHMP4A;ATP6V1E1;PKD2;TAF9;NUFIP1;ATP5IF1;ANK2;PGR
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.24359585945164025,-0.6352853009741912,0.8937093275488069,0.9834460829595628,1.0,9/14,51.20%,PRORP;RPP30;POP7;TSEN34;ELAC2;RPP21;POP1;RPP40;POP5
prerank,3'-5' exonuclease activity (GO:0008408),0.20855589703946592,0.6317014475723657,0.9499192245557351,0.992076835110955,1.0,11/45,16.69%,WRN;RAD50;POLG;EXD1;NOCT;DIS3L;USB1;RAD9A;DIS3;EXOSC10;ERI3
prerank,sequence-specific mRNA binding (GO:1990825),0.27784992550972587,0.6226490433125794,0.8963531669865643,0.9956592201576555,1.0,5/10,30.61%,SSB;SHFL;DHX9;ETF1;FMR1
prerank,death receptor activity (GO:0005035),0.27303158215776274,0.6149520636123396,0.888045540796964,0.9977934558672636,1.0,2/11,7.90%,NGFR;TNFRSF14
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.21454053205042148,0.6136022470127522,0.9586092715231788,0.9960005935094318,1.0,13/33,25.20%,DCP2;NOCT;XRN1;DIS3L;USB1;DIS3;EXOSC10;ERI3;PARN;PAN2;PNPT1;ANGEL1;EXOSC5
prerank,RNA methyltransferase activity (GO:0008173),-0.21779753393919007,-0.6111496210633949,0.9337899543378996,0.9938687358404852,1.0,9/19,42.03%,TRMT13;FTSJ3;TRMT9B;METTL8;BCDIN3D;FBL;TRDMT1;FBLL1;METTL4
prerank,transaminase activity (GO:0008483),0.27428368117065444,0.6098670038115597,0.901840490797546,0.9955469942176458,1.0,3/11,22.27%,ABAT;AGXT;PSAT1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.24235940710711637,-0.6003292895947769,0.9578059071729957,0.9959146879169034,1.0,10/12,53.73%,GPR88;RRH;OPN1MW3;OPN1MW;ELOVL4;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.17658606129329424,-0.6000014234947048,0.9753694581280788,0.9925904387492375,1.0,19/42,37.68%,CCND1;CNPPD1;CDKN1A;CCNF;CCNG1;CCNC;CCNK;HEXIM2;CCNE2;CDK5R2;CCNE1;CCNQ;CDKN2D;INCA1;CKS1B;CCNB2;CCNT1;CCNA2;CCNB1
prerank,snRNA binding (GO:0017069),0.19586900346342456,0.5997373942960375,0.9751655629139073,0.9988209398100051,1.0,6/42,16.30%,RBM41;SNRPA1;SF3B3;RNPC3;GEMIN5;DDX21
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.24312295868786757,0.5747269024179247,0.9407114624505929,1.0,1.0,5/13,24.33%,TRMT10B;THUMPD3;FTSJ1;METTL1;TARBP1
prerank,5'-nucleotidase activity (GO:0008253),0.24014130081884028,0.5721349701950701,0.9344569288389513,1.0,1.0,2/13,10.23%,NT5C;NT5DC1
prerank,microtubule minus-end binding (GO:0051011),0.23977437397318394,0.5705388735964302,0.9502762430939227,1.0,1.0,3/13,15.12%,TUBGCP4;TUBGCP2;TUBGCP5
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.19893279729852778,-0.569364834294994,0.9736842105263158,1.0,1.0,1/21,1.20%,GRIK2
prerank,mRNA methyltransferase activity (GO:0008174),0.247834274952919,0.5639798743601078,0.9349005424954792,1.0,1.0,12/12,75.24%,METTL16;PCIF1;CMTR1;METTL3;CMTR2;TRMT61B;NSUN2;RNMT;TRMT61A;METTL14;TRMT10C;METTL8
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.18515692144426335,0.561663714971432,0.9860627177700348,1.0,1.0,13/40,24.33%,HNMT;RRP8;COMT;THUMPD3;AS3MT;DNMT3A;PEMT;CARNMT1;LRTOMT;ICMT;METTL2B;METTL2A;TARBP1
prerank,vitamin D receptor binding (GO:0042809),-0.21849004441898573,-0.5600429693305813,0.9550321199143469,1.0,1.0,3/14,17.25%,MED30;TAF11;RXRA
prerank,GABA receptor binding (GO:0050811),0.2504025258638276,0.559408759901861,0.9302325581395349,1.0,1.0,2/11,11.94%,TRAK1;JAKMIP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.22559327588640082,-0.5560336174831209,0.9693877551020408,1.0,1.0,7/11,42.81%,RPS3;HMCES;NEIL2;APEX1;APLF;NEIL1;NEIL3
prerank,exoribonuclease activity (GO:0004532),-0.22078817031575473,-0.5467145409699627,0.957983193277311,0.999612635785427,1.0,7/12,45.39%,EXOSC2;EXOSC4;EXOSC1;EXOSC3;EXOSC8;EXOSC9;CNOT7
prerank,nucleotidase activity (GO:0008252),-0.20555681865879255,-0.5458549817832592,0.9761388286334056,0.9963439543547643,1.0,4/15,19.75%,BPNT2;NT5C2;NT5C3A;ACP3
prerank,nuclear export signal receptor activity (GO:0005049),-0.2242710175249468,-0.5426590427707422,0.971677559912854,0.9938016215828427,1.0,4/11,27.78%,XPO7;XPO1;NUP42;XPO6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2412415627676603,0.540508034884329,0.9485148514851485,1.0,1.0,2/10,15.47%,CDKN2B;KAT2B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.2208061061568268,-0.5386751402879241,0.9688796680497925,0.9914722461113092,1.0,6/11,35.10%,NUDT16L1;NUDT3;NUDT16;DCPS;NUDT11;NUDT1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.22940363045521195,0.5300535370952911,0.9593023255813954,1.0,1.0,4/11,25.44%,SLC22A4;SLC22A3;SLC25A20;SLC25A29
prerank,N-acyltransferase activity (GO:0016410),0.18276722245978194,0.5288920732200643,0.9879931389365352,1.0,1.0,2/32,4.31%,CERS5;CERS6
prerank,endodeoxyribonuclease activity (GO:0004520),-0.18260137586176195,-0.5260016505677133,0.9881796690307328,0.991227512674412,1.0,8/20,31.40%,RPS3;MRE11;DCLRE1C;ENDOV;EXO1;APEX1;ENDOG;FEN1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.23806240008893215,0.5242035816064295,0.9676190476190476,1.0,1.0,1/10,7.26%,B4GALT1
prerank,antiporter activity (GO:0015297),0.19747161101884764,0.5238567335349763,0.9731663685152058,1.0,1.0,4/20,15.15%,SLC35D1;SLC35D2;SLC35C1;SLC25A10
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.20678200720936477,-0.5163096828760534,0.9812108559498957,0.9900975099451872,1.0,6/12,41.45%,NDUFS7;AIFM2;CRYZ;NQO1;CBR4;CBR1
prerank,ubiquitin binding (GO:0043130),0.14965567280084216,0.4973921953597273,1.0,1.0,1.0,2/73,3.41%,SMAD3;NEDD4
prerank,purinergic nucleotide receptor activity (GO:0001614),0.20252680423859093,0.4937900857218742,0.9797047970479705,1.0,1.0,3/15,16.78%,P2RX1;P2RY1;P2RX4
prerank,methyltransferase activity (GO:0008168),0.14911517111857564,0.4659024983418412,0.998371335504886,1.0,1.0,8/46,19.02%,METTL27;AMT;RRP8;COMT;AS3MT;MGMT;CARNMT1;LRTOMT
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.15641988801322396,0.4620541184856126,0.9983948635634029,1.0,1.0,11/35,27.22%,FTO;TRPT1;DTWD1;ALKBH1;TYW3;PUS10;FTSJ1;DUS3L;QRSL1;QTRT1;GATB
prerank,glutathione transferase activity (GO:0004364),0.16858845168359962,0.4544910193457712,0.9896551724137931,1.0,1.0,2/23,11.84%,GSTK1;GSTA3
prerank,tRNA methyltransferase activity (GO:0008175),0.17454455745017172,0.43114908088310516,0.994263862332696,1.0,1.0,6/16,24.33%,THUMPD3;TYW3;FTSJ1;METTL2B;METTL2A;TARBP1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.17657397526834506,0.4059124449331264,0.9960707269155207,1.0,1.0,11/11,82.35%,CHRNA5;CHRNB1;CHRNB2;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA3;CHRNA9;CHRNA7;CHRNA4
prerank,N-acetyltransferase activity (GO:0008080),0.15640711916711428,0.4002348225918557,0.9980952380952381,0.9984902050181997,1.0,3/19,15.47%,ESCO1;NAT2;KAT2B
prerank,ribonuclease P RNA binding (GO:0033204),-0.15812104970993102,-0.3692845898334971,1.0,0.9997272297243639,1.0,6/10,51.20%,RPP30;POP7;RPP21;POP1;RPP40;POP5
